PMCID,ID,Label,Selected Text,Start,End,Valid Prompt
5773922,12853,significantly increase,plasma levels of marine n-3 fatty acids,6463,6520,True
5773922,12853,significantly increase,increased significantly in the fish and krill groups compared with the control,6520,6599,True
3493727,13079,significantly decreased,"longer mean recovery time (10.5 minutes vs 7.9 minutes, p=0.027",5718,5781,True
5801240,12225,no significant difference,"At week 52, the least squares mean",5521,5556,True
5801240,12225,no significant difference,"change (95% CI) from baseline in HbA1c was − 0.6% (− 0.7, − 0.5), − 0.6% (− 0.6, − 0.5), and − 0.7% (− 0.8, − 0.7) in the ertugliflozin 15 mg, ertugliflozin 5 mg, and glimepiride groups, respectively",5556,5755,True
5773985,13176,no significant difference,There was no significant difference between the two groups regarding the onset of action,5105,5194,True
5819580,12936,significantly increase,"The time to first use of rescue medication was significantly longer versus placebo with meloxicam IV 60 mg (P<0.05),",5782,5916,True
1224861,11633,significantly decreased,30-day mortality	3.4	7.5	0	0.06,17854,17977,True
5984011,11705,significantly increase,"there was a significant difference in terms of sexual desire (p=0.002), lubrication (p=0.002), orgasm (p=0.004) and pain (p<0.001) after eight weeks of the intervention among the three groups",7775,7966,True
3953523,13338,no significant difference,"The VAS, KOOS and ROM were improved after 4 weeks of administration in both groups, but the differences between the two groups were not statistically significant.",4725,4888,True
5809703,11677,significantly increase,"the incidence and dose of additional ephedrine were significantly higher in Group P2.5 (31.9%; 0 [0–20]) than in Group P1.5 (10.6%, P = 0.012; 0 [0–5], P = 0.007, respectively).",5659,5836,True
5983010,13224,significantly increase,Macular sensitivity increased from a mean (SD) of 25.9 (2.4) dB at baseline to 27.3 (2.3) dB at 90 days (P=0.030) in the DHA group only (between-group differences P<0.19).,5287,5493,True
29047,11553,no significant difference,"There were no differences in respiratory rates, oxygen saturations, arterial pH and arterial partial carbon dioxide tension (PaCO2) between the groups",2299,2460,True
3698199,12901,no significant difference,"Treatment superiority of TAU + SWT was neither confirmed by interaction effects (time x condition) for SUD or PTSD symptoms, nor by a group difference for SUD diagnostic status at post-treatment.",4452,4648,True
3698199,12901,no significant difference,"Treatment superiority of TAU + SWT was neither confirmed by interaction effects (time x condition) for SUD or PTSD symptoms, nor by a group difference for SUD diagnostic status at post-treatment.",4452,4648,True
3636841,12308,no significant difference,Majority of kids of both group A and B scored 3 (Frankl Behavior Rating Scale) before and after the treatment showing no statistical difference in their behavioral score (P = 1).,4057,4256,True
3733748,12788,no significant difference,"Compared with the placebo group, the mean baPWV did not improve in the cilostazol group",5404,5492,True
1193545,11395,no significant difference,No significant differences were found in any of the outcome measures between the BNHS group and either of the comparison groups,5251,5378,True
3707735,12036,significantly increase,"Group A patients also showed significant: 1) improvement in the degree of dyspnea (VAS: p < 0.05; Borg: p < 0.05; MRC: p < 0.001; BDI1: p < 0.05; BDI3: p < 0.03), and independence level in activities of daily living (p < 0.03); 2) improvement in quality of life in activity section (- 6.63 pt) and in total score (- 5.43 pt); 3) exacerbation number decrease (p < 0.02). No significant differences were found (end of study vs baseline) in group B",5306,5751,True
3575558,11776,no significant difference,Degree of improvement in total naso-pharyngeal symptoms between subject with and without heated humidifier (p = 0.043).,19521,19658,True
3672764,13147,significantly decreased,"All treatment groups were characterized by a general reduction from baseline in hs-CRP from initiation of treatment to the safety follow up at day 31 (Figure 4). At day 4, these reductions were significantly greater with rilonacept plus indomethacin (P < 0.0001) and rilonacept monotherapy (P = 0.0142) relative to indomethacin monotherapy.",28882,-1,True
3744251,12436,significantly increase,"annual average total costs per-test for study group and control group was 1.57 ± 0.23 vs 2.08 ± 0.38, P value 0.019 respectively,",4894,5041,True
5851005,12918,no significant difference,"during the AP, the aprepitant and standard therapy groups achieved identical CR rates (98.0%, P =1.000).",6381,6486,True
1994017,11659,significantly decreased,fondaparinux significantly reduced the occurrence of the primary efficacy outcome (death or recurrent myocardial infarction) by 14% (p=0.008).,2434,2577,True
5729492,12667,,no data,-1,-1,False
5755650,13388,no significant difference,The absolute change of urinary albumin excretion showed no significant difference between the amlodipine group and the benidipine group,21269,21405,True
5836868,13371,no significant difference,Patients randomized to alogliptin achieved lower HbA1c levels than the placebo group in all baseline HbA1c categories without differences in hypoglycaemia rates,10345,10609,True
4272222,13125,significantly increase,"In the SSTS group, patient global assessment and health care provider global assessment ratings of good or excellent were greater than placebo at all time points (P < 0.01).",5447,5641,True
3733617,13259,no significant difference,"did not find a statistically significant effect of a small unconditional non-financial incentive (in the form of a pen) on survey response rates amongst GPs (Odds ratio, 95% confidence interval: 1.85",4303,4503,True
5762815,12958,no significant difference,no significant differences between the intervention and control clusters in the proportions of facility births (53% vs 54%; p=0·73) and deliveries facilitated by skilled birth attendants (54% vs 56%; p=0·53,44620,44860,True
1618389,11428,no significant difference,The average number of correct answers for LMQs and OEQs showed no significant difference (p = 0.93).,5411,5512,True
3718630,12344,significantly increase,"Women in the intervention group self-reported walking for leisure for 14 min/day more than those in the control group at 28 weeks’ gestation (95% CI 5 to 23 min, p = 0.003).",54878,55052,True
1783667,11504,no significant difference,"Sallis Self-Efficacy for Diet and Exercise
UC	4.1 (.58)	3.8 (.71)	3.9 (.71)	3.8 (.66)	14.51***	1.33
MLP	4.1 (.59)	4.1 (.54)	4.0 (.59)	4.1 (.62)",49048,49461,True
1403758,12922,no significant difference,"There was some evidence that averaged over fenoterol dose and genotype terbutaline decreases FEV1 compared to placebo (P = 0.027) by an estimated 1.58 (SE 0.68) percent points. Only for genotype I/I this decrease reached statistical significance (see table 5). Adjustment for multiple comparisons, by for instance the Bonferroni correction, reduced all these findings to non-significance.",31003,31441,True
3478157,12371,no significant difference,"There was no significant difference in the changes in sperm count, semen volume and sperm motility between the two treatment groups",35575,35706,True
102323,11299,significantly increase,The improvement in Lequesne's functional index also differed significantly between the EA and placebo group,5312,5419,True
1810369,11226,significantly increase,Statistically significant (P < 0.05) improvements in favor of the intervention were present for the HIT score,3910,4037,True
3606616,11813,significantly decreased,"Experimental group infants, who latched on, had a significantly shorter median time from start of intervention to regular latching on than control infants, 2.0 weeks (Q1 = 1.0, Q3 = 3.7) vs. 4.7 weeks (Q1 = 2.0, Q3 = 8.0), (p-value = 0.020).",5381,5667,True
5723032,12286,,no data for CSF alone,-1,-1,False
5986495,13204,significantly decreased,Hunger ratings were lower in SUC as compared with WAT (t17 = −2.71; p < 0.05) and NNS (t17 = −2.66; p < 0.05).,41166,41339,True
4272222,13123,significantly increase,"Summed pain intensity difference over 48 hours was significantly higher in the SSTS group than in the placebo group (least squares mean [SEM], 105.60 [10.14] vs 55.58 [13.11]; P = 0.001).",5068,5273,True
59901,11224,significantly increase,7/14 questions previously rated as mis-specified in the Intervention Group had all dimensions described at follow-up (p = 0.008) while the Control Group did not show any changes from baseline,4954,5162,True
4282697,12279,significantly increase,"The 2- and 5-year recurrence-free survival rates were 68.5, 41.4 and 56.8, 26.2 % in groups A and B, respectively. Those differences were also statistically significant (log-rank test p = 0.0020).",4510,4724,True
3558408,12613,significantly increase,The ventilation rate (median (IQR)) at a C:V ratio of 15:2 (14 (13–15) per minute) was significantly lower than at a ratio of 3:1 (30 (29–30) per minute,22371,22523,True
4166055,12824,no significant difference,"The mean SBP at min 2 and min 5, mean of DBP at min 2, 5, and 15, mean of HR at all time points and mean of MAP at min 2 and 15 between groups were no significantly different (P > 0.05),",4023,4227,True
5758851,12004,significantly increase,Tear volume in the 0.1% CO treatment group was significantly greater than those in the other groups (all P < 0.01,30428,30558,True
3652643,13001,no significant difference,"15 (28%) of the control group and 11 (22%) of the intervention group were receiving medication for mood problems and this difference was not statistically significant (chi-square = 0.15, P = 0.70",43665,43877,True
5830087,12880,no significant difference,All other clinical endpoints also favored the BTH1677 arm but none statistically differed between arms,8030,8132,True
5851005,12917,significantly increase,A CR was achieved by 80.0% in the aprepitant group compared with 56.0% in the standard group during the OP (P =0.018)as well as during the DP,6229,6370,True
5883519,12469,significantly decreased,"subjects in the rhGH treatment group had significant reductions in BMI standard deviation scores (SDS) compared with controls (2.32 ± 0.85 vs. 2.80 ± 0.61; P = 0.041),",4762,4947,True
3488187,12205,significantly increase,"significant improvement in progression-free survival with erlotinib (unadjusted HR 0·83, 95% CI 0·71–0·97, p=0·019; adjusted HR 0·80, 0·68–0·93, p=0·0054);",21463,21619,True
5789504,12488,significantly increase,ease of intubation were found to be more in C-MAC D-Blade group than in Macintosh group (P < 0.05).,4760,4880,True
1904193,11499,no significant difference,"However, the 95% confidence limits were overlapping, suggesting no statistical difference between the groups",5735,5843,True
5801240,12227,significantly decreased,"greater reductions from baseline in SBP were observed in the ertugliflozin groups at week 52 (Fig. 2c). LS mean changes from baseline at week 52 were − 3.8 mmHg (− 4.9, − 2.7), − 2.2 mmHg (− 3.4, − 1.1) and 1.0 mmHg (− 0.1, 2.1) in the ertugliflozin 15 mg, ertugliflozin 5 mg, and glimepiride groups, respectively.",34985,35339,True
5801240,12227,significantly decreased,(p < 0.001 vs. glimepiride).,35510,35556,True
5801240,12227,significantly decreased,Reductions from baseline in DBP were also observed in the ertugliflozin groups compared with the glimepiride group (p < 0.05;,35556,35702,True
5891027,11787,significantly decreased,Phenylephrine infusion significantly decreased heart rate (P = 0.02) and pulse pressure variation (P < 0.001).,11946,12090,True
5041384,12763,significantly increase,Yoga group showed statistically significant (P < 0.001) reduction in aggression,4533,4639,True
1891439,11577,significantly decreased,"Median (95% confidence interval) fever clearance times were 92 hours (84–114 hours) for gatifloxacin recipients and 138 hours (105–164 hours) for cefixime-treated patients (Hazard Ratio[95%CI] = 2.171 [1.545–3.051], p<0.0001).",7958,8185,True
3664372,13013,no significant difference,"In the AAIR group 209 patients (29.6%) died versus 193 (27.3%) patients in the DDDR group (unadjusted HR 1.06; 95% CI 0.88 to 1.29, p=0.53).",27919,28060,True
5498774,12955,significantly decreased,statistically significant reduction in hospital stay from 17.8 to 11.8 days (p<0.002) for patients treated with broad-spectrum antibiotics,5570,5725,True
4917592,12327,no significant difference,"Daytime heartburn during treatment was a borderline significant predictor (adjusted OR 2.66; 95 % CI 0.93–7.63; p = 0.0678),",29098,29240,True
1570354,11653,no significant difference,median number of days with no use of relief medication was 63% in the SFC group and 61% in the FBC group,25369,25474,True
1570354,11653,no significant difference,There was no statistical difference between the groups,25616,25671,True
4756949,12501,significantly increase,"FEV1, FVC, FEF25 and FEF25–75 values decreased on postoperative day 1 (39.7%, 37.4%, 27.7%, 51.8% respectively) in the open surgery group and they were significantly lower in laparoscopic group (29.9%, 32.5%, 23.2%, 44.5% respectively).",4790,5060,True
58836,11371,no significant difference,Intensity of prescribing of blood pressure lowering drugs was not significantly different between the two groups,4252,4365,True
3580671,12420,significantly decreased,shorter duration of meropenem therapy (7 (6 to 8) days vs. 8 (7 to 10) days; P = 0.035),6309,6414,True
3261693,12167,significantly decreased,postsurgical uveitis recurrence rate was lower in implanted than non-implanted eyes (26.5% vs 44.4%; P = 0.0433,4822,4950,True
88884,11186,no significant difference,People who use tobacco are popular and glamorous . .	93.2	91.3	N.S.	96.9	N.S,24873,25064,True
3707772,12292,no significant difference,"levels of parathormone and of 1,25diOH-vitamin D3 significantly increased in both groups,",7281,7371,True
3707772,12292,no significant difference,"1,25-di-OH-vitaminne D3, ng/l
49.1 (18.7)*
49.3 (18.4)*
0.97
25 – 60",26377,26650,True
5812877,11844,no significant difference,Saliva flow rate was not significantly (p = 0.949) different between the hot (0.32 ± 0.08 ml/min) and cool (0.27 ± 0.05 ml/min) trials,5861,6015,True
3606371,12096,significantly decreased,"The percentage activity impairment due to health in all patients, as assessed by the WPAI:GH instrument, was improved more substantially in the ETN + MTX group compared to the DMARD + MTX group, by 49% compared to 29%, respectively",40001,40232,True
4021157,12658,no significant difference,There were no statistically significant differences in levels of satisfaction between the three trial groups.,41784,41894,True
3474775,11807,,"study of lisinopril (L) (10 mg daily) vs L-placebo in combination with pravastatin (P) (20 mg daily) vs P-placebo among participants receiving ART with undetectable HIV RNA levels, there is no comparison between placebo groups",-1,-1,False
3698174,12345,,"study of lisinopril (L) (10 mg daily) vs L-placebo in combination with pravastatin (P) (20 mg daily) vs P-placebo among participants receiving ART with undetectable HIV RNA levels,",-1,-1,False
5369684,12957,significantly increase,"people with dementia receiving iCST rated the relationship with their caregiver more positively (MD = 1.77, 95% CI 0.26–3.28; p = 0.02),",17678,17832,True
5817800,12803,no significant difference,There were no differences in the macular hole closure rate between groups (p = 0.85).,6289,6392,True
5838794,12270,no significant difference,weight losses did not differ by condition,7148,7189,True
1501010,11336,no significant difference,"From the 31 experimental group patients that completed T1 assessments, 7 (22.6%) improved clinically compared to 3 (10.7%) of the 28 control patients (chi square = 1.472, p = 0.22). At T2, 15 of the 29 experimental group (51.7%) and 11 of 26 (42.3%) controls were improved (chi square = 0.488)",27099,27393,True
2526991,13094,significantly increase,The duration of therapeutic effect of Garcinia kola was longer than the placebo (p > 0.001).,6251,6367,True
3872578,13055,no significant difference,The mean arterial blood pressure was not statistically significant different between two groups (P = 0.72).,15296,15420,True
57751,11284,significantly decreased,Triglycerides were significantly reduced by about 23.0% and fibrinogen by about 14.0%.,3707,3794,True
57751,11284,significantly decreased,All of these effects were highly significant (P < 0.0001).,3868,3944,True
3525331,13143,no significant difference,there were no significant differences between the two groups in analgesics consumption (P > 0.05).,7852,7979,True
5986584,13171,significantly increase,Subjects in the intervention group had significantly more weight loss (WL:−3.7 ± 0.5 kg; Control:−1.6 ± 0.5 kg; p=0.007),6579,6700,True
4681166,12811,no significant difference,There were no differences in the changes between the different supplemental groups for the absolute FFM changes,43507,43618,True
4391304,12993,significantly increase,fecal fat level after FM intake was significantly increased compared with that observed before FM intake in the LG2055-containing active FM group but not the control FM group lacking LG2055,5712,5901,True
3717762,13285,no significant difference,"AEs were reported for 40.5% (122/301) of bimatoprost PF and 44.1% (130/295) of bimatoprost patients (p=0.382),",33793,33904,True
4210946,13220,significantly increase,"a significantly greater proportion of girls in the intervention group (27/48, 56%) compared with the control group (14/71, 20%) identified breast cancer",47912,48065,True
4391192,13377,no significant difference,No group differences were found in urinary melatonin levels and cortisol levels,5157,5237,True
5749033,12679,no significant difference,no significant changes were found in the MVC (P>0.05 for both groups).,4106,4177,True
3580725,12671,significantly decreased,"Patients treated with SLED needed fewer blood transfusions (1,375 ± 2,573 ml vs. 1,976 ± 3,316 ml, P = 0.02) and had a substantial reduction in nursing time spent for renal replacement therapy (P < 0.001)",7755,7994,True
5457616,12136,no significant difference,"there was no statistically significant difference in Urea, Creatinine, Triglyceride, Cholesterol total, HDL-C and LDL-C between or within the groups at the end of the study (P > 0.05).",30963,31165,True
3767897,11715,no significant difference,The radiographic and clinical outcomes did not show significant difference between two groups. The average bone union period was 11.7 weeks in group I and 12.1 weeks in group II,4482,4659,True
3580725,12672,significantly decreased,"patients in the SLED-BD group had significantly fewer days of mechanical ventilation (17.7 ± 19.4 vs. 20.9 ± 19.8, P = 0.047) and fewer days in the ICU (19.6 ± 20.1 vs. 23.7 ± 21.9, P = 0.04).",7528,7755,True
4132222,12720,significantly increase,"proportion of participants with a $10% decrease in average lesion area was significantly higher in the CPA group than the placebo group at weeks 3 (P=0.05) and 6 (P=0.02),",4943,5149,True
5001793,13306,no significant difference,Pain intensity in the PACU and morphine consumption was not significantly different between the TAP and ILI+IHG groups;,27554,27674,True
5812981,12406,no significant difference,No significant differences were observed across groups at 12-week follow-up in terms of adherence to pharmacological treatment (Fisher exact test P value=.98).,30294,30471,True
4173573,12645,significantly decreased,The incidence of postoperative rescue analgesia was significantly higher in group R compared with groups RM and RD.,4414,4530,True
1578590,11411,significantly increase,"Beta-blocked patients who received early atropine (Group A&B) had a significantly lower double product (p = 0.008), a higher mean test time (p = 0.010)",4832,4984,True
3532036,12512,significantly increase,"the one-year survival rates were 93.3% and 46.6%, respectively (χ2 = 7.777, P < 0.05).",4081,4199,True
5758851,12006,no significant difference,"the 0.001% CO extract group did not differ significantly from the EDE and BSS groups in terms of TBUT. (1.68 ± 0.14 s; P = 0.27 and P = 0.98, resp.).",31248,31431,True
65683,11644,significantly increase,"Mean of daily steps was significantly higher in the exercise group from about 6,800 to over 8,500 steps (P < 0.01).",4393,4526,True
3636944,12623,no significant difference,The intergroup comparison of PI scores and PPD showed no significant difference (data not shown).,11949,12046,True
1526611,11606,no significant difference,Celecoxib was not significantly different from placebo in this analysis (P = 0.069).,6838,6940,True
3580299,12408,no significant difference,"The number of ESWL sessions was 1.34±0.65 and 1.41±0.85 in groups 1 and 2, respectively (p=0.33).",4699,4797,True
4769147,13463,significantly decreased,"Llevels of bilirubin above 200 umol/l were found in 8 cases (16%) in the CLF group and in 18 cases (36%) in the control group. This difference is statistically significant (p-value 0.02),",49129,49317,True
1794254,11232,no significant difference,URO transiently increased urine sodium excretion from 22 ± 16 μmol/min (mean ± SD) to 78 ± 41 μmol/min (P < 0.05) and there was no effect of placebo (29 ± 14 to 44 ± 32).,4085,4256,True
1326200,11222,no significant difference,"There were no statistically significant carryover effects for any of the baseline, end challenge, or recovery values for systolic and diastolic blood pressure, oxygen saturation, heart rate, and respiratory rate",44232,44443,True
5737953,13688,significantly decreased,The primary parameter was the difference in median time to complete encrustation or epithelialization,4471,4573,True
5737953,13688,significantly decreased,The predefined clinical situation was reached after a median of 4 days with propolis and after 5 days with aciclovir (P < 0.0001).,4815,4963,True
5769198,12114,no significant difference,There was a nonsignificant improvement between the groups for the social interaction scores after 5 years (P = 0.141).,20363,20499,True
1849920,13853,significantly increase,"the mean urinary mercury concentration was significantly greater among children in the amalgam group (0.9; range, 0.1–5.7 μg/g creatinine) than among children in the composite group (0.6; range, 0.1–2.9 μg/g creatinine) (p < 0.001).",21604,21853,True
4788673,12137,no significant difference,"comparing group 3 (sandwich e-learning) with the other groups (post-course learning alone, pre-course learning only, and classroom-based), no significant differences were found both in test D and test E (p = 0.3; p = 0.5)",21214,21470,True
5725027,13712,no significant difference,The pressing times of analgesic pump and rescue tramadol were not significantly different between the two groups (P > 0.05).,5299,5424,True
5789502,13615,significantly decreased,Postoperative pain scores and postoperative agitation score were significantly lower in Group D0.3 than D0.15 at all time intervals (P < 0.05).,4875,5060,True
3616693,13526,significantly increase,Intergroup comparisons showed that the MMC group had the longest sustained IOP-decrease period,18775,18869,True
3775760,13798,no significant difference,"There was an apparent response in area under the curve (AUC) for Rev (p = 0.012 before correction for multiple tests) for the 12 mg Opal-HIV-Gag(c) group compared with pooled placebo participants (n = 8) (data not shown; these data are described more fully in a separate manuscript), but this was not significant",28804,29117,True
3767897,11718,no significant difference,There was no significant difference in the mean KSS between group I and group II (92.1 vs. 94.3; p=0.419).,17592,17699,True
5980306,11674,significantly increase,Dust and endotoxin concentrations were significantly reduced in the LD units compared to the HD units.,34816,34919,True
5980306,11674,significantly increase,"In the HD units, the maximum number of 400 viable fungal CFU (28.3 × 103 CFU/m3) was reached very often, with an odds ratio of 102.65 (95%CI 20.54–994.70) for HD versus LD units",42009,42208,True
4769147,13461,no significant difference,"We found no evidence of difference between treatment groups in the rates of exclusive as well as any breastfeeding at discharge (p-value 0.2 and >0.99 respectively), 3 months (p-value 0.12 and 0.10) and 6 months of infants’ age (p-value 0.45 and 0.34 respectively).",11235,11501,True
5819580,12932,no significant difference,"AEs were mild-to-moderate in intensity, and their incidence was similar across the three treatment groups.",5034,5141,True
4717613,13510,significantly decreased,"In the control group, the patients’ albumin levels decreased to 25.71 % of the baseline on the postoperative third day, but this reduction was only 14.69 % for nutrition program group patients and the difference was statistically significant (p < 0.001).",5204,5476,True
5725027,13714,no significant difference,the incidence of vomiting and antiemetic drug administered had no difference between the two groups,30879,30978,True
3656395,13733,no significant difference,"the comprehensive programme did not result in statistically significant improvements in the diabetes outcome measures (HbA1c, blood pressure, cholesterol, BMI).",30707,30868,True
4666408,12872,no significant difference,"mortality in malignancies was performed, with no differences between the two groups (active treatment: 20/221 vs. placebo 19/222; χ 2:0.03; P = 0.86).",46025,46220,True
4113172,13560,significantly decreased,"In both ILS and metformin groups, CRP values at EOS were significantly lower than the corresponding placebo group values",25096,25216,True
1277845,11459,no significant difference,"Postprandial lipemia (dAUC of triacylglycerol) was, compared to the control trial, +2% (P = 1.00), -14% (P = 0.24), and -15% (P = 0.23) in the 30, 60, and 90 min walking trials, respectively",4581,4771,True
3931289,13625,no significant difference,there was no difference between groups in change in FEV1 or FVC percent,22729,22812,True
4947120,12241,no significant difference,"SCCQ-rewarding	CT (sd)BT (sd)	8.35 (5.12)7.95 (6.73)	4.23 (4.95)4.18 (6.12)	5.41 (6.08)5.33 (5.92)	1.120.91	0.660.74
SCCQ",33349,33750,True
5654748,13472,significantly increase,The Web 2.0 group had a significantly greater average number of days per week with a step comment in comparison with the Web 1.0 group at 0–3 months,39915,40063,True
2797957,13880,no significant difference,"no difference in sensory scale (P = 0.65; SEM 3.3; 95% CI −5.39 to 8.44), affective scale (P = 0.81; 1.3; −3.0 to 2.4), VAS (P = 0.24; 1.0; −0.91 to 3.4), and present pain intensity (P = 0.57; 0.53; −0.79 to 1.4) between study cohorts",21524,21826,True
5710015,12913,significantly increase,the head was tilted back more often during intubation for N group than for M and A groups (p < 0.01).,20094,20216,True
5852933,13450,significantly increase,sodium ascorbate application significantly improves bond strength compared with control and PA application [,17935,18043,True
5840469,13033,significantly decreased,"Times of balloon dilatation in the PGA plus stent group were less than those in the stent group [4 (2-5) vs 6 (1-14), P = 0.007].",5851,6015,True
4717613,13511,significantly decreased,Complications developed in 12 patients (44.4 %) in the control group compared to 6 patients in the nutrition group (p = 0.049).,5476,5624,True
1177952,11247,significantly decreased,LVEF ≤ 30% was observed in 18% in the controls and in 12% of the GIK group (P = 0.01).,6677,6763,True
4177066,13781,significantly decreased,"a significant difference between groups in favor of the late intervention group was found for the acquisition of positive attitudes towards early reading aloud (p < 0.01), early exposure to music (p < 0.001) and parental socialization (p = 0.03",25284,25528,True
3549213,13413,significantly decreased,outcome of agitation was significantly reduced in the intervention group compared with controls over 26 weeks (time by group interaction adjusted for covariates: p=0.011).,7935,8107,True
4815896,13486,no significant difference,Levels of sRAGE decreased significantly in both the MPT and placebo groups (p < 0.002),33388,33492,True
5030453,13598,no significant difference,"within the three groups differences in the reported functional activity at the three visits did not reach statistical significance,",31583,31715,True
3606612,13639,no significant difference,Hb in the HIP group was 117 g/L and 113 g/L in the IV sucrose group (p = 0.37).,4850,4930,True
5789502,13616,no significant difference,The groups were comparable with time to discharge (P = 0.071).,17033,17112,True
3606612,13641,significantly decreased,the serum ferritin was significantly higher in the IV iron sucrose group {85.5 ug/L in HIP and 244 ug/L; p = 0.004}.,5006,5123,True
3643086,13738,no significant difference,The intrahospital mortality rate was 26% in the statin group and 45% in the placebo group (P = 0.17).,6055,6173,True
3698086,11916,significantly increase,"In DH+ TO lungs, the relative abundance of elastin-containing secondary crests was increased as compared to DH lungs (P = 0.01),",55663,55809,True
3636850,13635,significantly decreased,The OHI-S was found to be significantly low in the fluoridated group at the 12 months time interval (P < 0.05).,10439,10567,True
4360612,13447,significantly increase,83% of the surgery group and 25% of the NSM group exhibited a pain improvement of ≥20 points (p<.0001).,48243,48347,True
1797029,11310,no significant difference,a trend toward a shorter median time to treatment failure among women with HER2-positive tumors (2.3 versus 4.2 months; P = 0.067).,6941,7090,True
5844532,13772,significantly decreased,"recurrence was significantly higher in the placebo group than in the Equitend® group (71.4% vs 16.6%, p = 0.02442).",19479,19606,True
3714436,12342,no significant difference,"the EQVAS, continued to show a small difference that favoured early pramipexole but was of doubtful clinical significance",23479,23601,True
3575612,13492,no significant difference,There were no adverse drug reactions,4921,4958,True
1074719,11489,no significant difference,median disease-free survival (66 months with Cisplatin vs. 73 in the nihil group) were similar in both arms,4968,5076,True
1913939,13521,no significant difference,No significant differences were found between the two groups on measures of stress or physical activity,6630,6733,True
5027814,12522,significantly decreased,"The overall ARR over the 11-year study period was lower in the early-treatment group than in the delayed-treatment group, resulting in a 19.1% reduction in risk of relapses (risk ratio [RR] 0.8094 [95% CI 0.7090–0.9242], p = 0.0018;",87193,87443,True
4710681,13317,no significant difference,"The study showed similar response rate, PFS, and OS in both groups",38852,38918,True
3682309,13843,no significant difference,"Duration RRT prescribed, hrs	146 ± 240	145 ± 156	0.88",30348,30464,True
3563445,12823,significantly decreased,"the placebo group children had higher levels of Clostridium difficile et rel at 18 months of age as compared to the LGG group children (1.19 ± 0.85% and 0.78 ± 0.60%, respectively, p=0.047).",37332,37540,True
5850179,13858,no significant difference,There was no difference between groups in infarct size,20360,20415,True
3685778,12071,significantly increase,"Sildenafil group fetuses demonstrated a significant decrease in systolic/diastolic ratios (0.60 [SD 0.40] [95% Cl 0.37-0.84], P=0.000), and pulsatility index (0.12 [SD 0.15] [95% Cl 0.02-0.22], P=0.019) for the umbilical artery and a significant increase in middle cerebral artery pulsatility index (MCA PI) (0.51 [SD 0.60] [95% Cl 0.16-0.85], P=0.008).",4111,4515,True
88884,11189,no significant difference,Advertising tells the truth about the effects of tobacco use. ............................	73.1	81.0	N.S.	79.9	N.S,25585,25814,True
3685700,13687,significantly increase,Plasma concentrations of ghrelin were significantly higher under conditions of TSD,4956,5038,True
1804280,11560,no significant difference,The differences between intervention and control groups were not statistically significant,38220,38310,True
3685700,13685,no significant difference,"ratings of sweet intensity or pleasantness of the yogurt samples with varying sucrose concentrations did not significantly (i.e., p < 0.05) differ between conditions",17308,17473,True
3770494,13698,significantly increase,Participants whose treatment assumption after final free recall was MPH showed significantly more anger (P = 0.031) and fatigue (P = 0.036) than those who answered placebo.,27807,28014,True
1974799,11289,significantly decreased,"Times to PR and PF were shorter with rizatriptan than with other oral triptans (median time to PR: 45 vs. 52 min, p < 0.0001; median time to PF: 100 vs. 124 min, p < 0.0001).",4081,4256,True
5815237,13504,significantly increase,Treatment with iNO was associated with delayed CHI3L1 recovery with a daily decline of 34% in the placebo group versus 29% in the iNO group (p = 0.012).,8282,8435,True
2921405,13779,significantly decreased,The prevalence of severe illness among children consuming prebiotic and prebiotics-fortified milk was 16% (95% CI: 5 to 26%; p = 0.004) lower than the control group.,46778,46944,True
2921405,13779,significantly decreased,Children in the prebiotic and probiotic fortified group showed a statistically significant 5% fewer days with high fever,47154,47275,True
4166058,13384,no significant difference,There was no significant difference between the groups in the need for nCPAP,4520,4596,True
5845721,13514,no significant difference,No differences in weekly MVPA or daily steps were observed between groups (p > 0.05).,6850,6956,True
5850768,13734,no significant difference,Immunogenicity was comparable between SB2 and INF with no statistically significant difference,32993,33087,True
5819581,13418,significantly increase,"in the group comparison analysis for the same variables between IPV group and HFCWO group, we observed a significant improvement in the IPV group maximal inspiratory pressure, maximal expiratory pressure, BCSS, and CAT",5636,5854,True
3540908,13323,no significant difference,"At the end of follow-up, 19 of 22 (86.3%) subjects in group 1 and 19 of 21 (90.4%) in group 2 were still in remission, with no significant difference between the two groups.",4541,4715,True
5516151,13662,no significant difference,Hazard ratios (HRs) comparing time to death or graft loss were 0.915 (95% confidence interval [CI] 0.625–1.339; p = 0.65) for belatacept MI versus cyclosporine and 0.927 (95% CI 0.634–1.356; p = 0.70) for belatacept LI versus cyclosporine.,9413,9913,True
57750,11248,significantly decreased,"Death or myocardial infarction						
 Eastern Europe	21.0	19.7		18.0	17.9	
 Latin America	16.1	15.7		14.1	13.2	
 North America	11.7	15.0		11.7	15.0	
 Western Europe	13.8	14.8		12.9	13.7	
 Overall	14.2	15.7	0.042	13.3	14.9	0.021",27420,-1,True
5863299,13725,significantly increase,"the levels of ET-1 and VWF had decreased in both groups, but the change in the treatment group from baseline was less than that of the control group. At 12 weeks of treatment, the ET-1 and VWF levels of both groups were significantly lower than at the baseline, but the decrease in the treatment group was significantly less than that of the control",30176,30525,True
3664374,13633,no significant difference,"there was a numerically greater improvement in BASFI with adalimumab than with placebo, the difference was not statistically significant.",39725,39863,True
2866241,12350,significantly increase,global assessment of syringe usability showed highly statistically significant differences (P < 0.0001) in favour of HC,6074,6193,True
3575612,13494,no significant difference,"The combination of grape extract and low-dose pterostilbene decreased BUN by 7.1% from baseline (P = 0.01), but this reduction was not significant when compared to placebo (P = 0.20).",13480,13698,True
1794469,11343,significantly decreased,"central venous catheter-associated blood stream infection in 16%, which were all significantly increased compared with the ultrasound group (p < 0.001",7558,7728,True
1794254,11234,,Total sodium excretion during URO and placebo infusions is shown in Figure 3 no figure 3,-1,-1,False
5516151,13664,no significant difference,Acute rejection rates and safety profiles of belatacept‐ and cyclosporine‐based treatment were similar,10983,11085,True
5976302,13659,significantly increase,"the treatment group exhibited significant improvement in pain/comfort (P = .048), physical health (P = .035), stair ascent time (P = .015",5955,6143,True
1914252,11464,significantly decreased,"Lipid levels decreased significantly in the aggressive treatment group (LDL-C reduction 20.8%; P < 0.001),",4928,5052,True
4745915,13840,no significant difference,"No significant differences could be detected for the fold change of CCR5+ and CD86+ pDC nor for the secreted amount of IL-6, IL-12p70, TNF-α, IFN-α, caspase-1, and MMP-9 upon IQ stimulation between trained and sedentary MS patients after 12 weeks",39658,39961,True
4710520,13442,no significant difference,"Diurnal systolic and diastolic BP were lower in the DTFC group than the latanoprost group; however, the difference between the groups was not statistically significant.",5965,6134,True
4861263,12688,significantly increase,Three IM immunizations of CN54 gp140 at either 20 or 100 μg elicited significantly greater systemic and mucosal antibodies than either IN or IVAG immunizations.,17377,17538,True
5866733,13627,no significant difference,"Serum AST, ALT, ALP, CK-MB, and TnI levels demonstrated no significant difference between the 2 groups",14481,14584,True
3770450,13466,no significant difference,"Osteocalcin
22.8 ± 1.0
22.9 ± 0.8
NS
CTX
0.38 (0.33–0.43)
0.39 (0.34–0.43)
NS",16716,-1,True
4644318,13801,no significant difference,"Number of patients with improved disability (measured by ODI < 20%) was not significantly different in PIL group (78% of cases) compared to the TF group (76% of cases), at 4 weeks (P = 0.21).",5624,5816,True
5644405,13240,significantly decreased,The end-pressure difference (intraocular pressure at 60 minutes vs. baseline) was significantly greater in the tube group (5.6 ± 3.6 mmHg; 41% change) than in the trabeculectomy group (3.2 ± 4.7; 23% change; P = 0.03).,4814,5052,True
3580751,11789,significantly increase,"All-cause mortality and length of stay increased (P = 0.028 and P = 0.038, respectively) in unit A between periods 1 and 2. In unit B, no change in mortality was observed (P = 0.22), while length of stay decreased between periods 1 and 2 (P = 0.002).",5451,-1,True
3525031,13581,no significant difference,Between groups differences in each follow up time were not statistically significant.,4747,4833,True
4301466,13157,no significant difference,"Defecation frequency was lower, but this was not significant",6150,6210,True
1626393,11358,significantly decreased,"The remediation group had a significant decrease in symptom days (p = 0.003, as randomized; p = 0.004, intent to treat) after remodeling, whereas these parameters in the control group did not significantly change.",6166,6414,True
3724383,13825,significantly increase,there was a better global improvement in the synbiotic + mineral oil group (P < 0.05).,5091,5198,True
4710815,13701,no significant difference,"Although the incidence of cardiac disorders was higher in the HandiHaler group (n=5 vs 2), the very small number of cardiac deaths, the small absolute risk difference and the wide CIs around the HRs, do not indicate any significant difference",33037,33280,True
4627615,13885,no significant difference,No adverse event reported after administration of the buccal spray or soft gelatin capsule,36743,36834,True
4265717,13571,significantly decreased,"70% reduction in UDI and IIQ scores was significant in the urodynamic testing group at 86.7% and 73.3%, respectively, compared with only 60.0% and 46.7%, respectively, in the office evaluation only group (p=0.001 and p=0.001).",19775,20003,True
5735484,13416,no significant difference,"Time for the first analgesic request was shorter in Group I (2.83 h) compared to Group II (4.43 h) and Group III (3.98 h), but there was no significant difference between the groups (P = 0.161) [",16902,17114,True
3641305,13758,significantly increase,"INH-DILI occurred in 78 % of the slow acetylators in the STD-treatment, while none of the slow acetylators in the PGx-treatment experienced either INH-DILI or early treatment failure",6282,6464,True
3651308,11692,no significant difference,There was no significant difference in IBS SSS or IBS-QOL score between medication or website groups,6159,6260,True
5827507,13501,significantly decreased,Synergistic use of 5% KNO3 and diode laser (Group 3) significantly reduced the DH pain,4563,4660,True
4588430,13579,no significant difference,"there was no evidence of difference in QOL scores (estimated treatment effect in favour of the telephone consultation group was 5.7 points, 95% CI − 2.9 to 14.3; p = 0.19).",5658,5831,True
529310,11479,significantly increase,"After the treatment the KPS is 89.00 ± 9.92 in the trial group, and 84.17 ± 8.84 in the control group, with a significant difference between the two groups (P = 0.028).",5637,5823,True
4354432,13694,no significant difference,No clinically significant findings for vital signs or physical examination results were observed,21526,21623,True
4733222,12654,,Participants held more positive attitudes toward the ePaper-based program than the app-based program. No data,-1,-1,False
5834094,11724,no significant difference,There was no difference between operator perception accuracy of the orientation of the axis of maximal gradient of a scalar field represented with colour mapping and dot mapping,33293,33470,True
3499555,13433,significantly decreased,"IncellDx mRNA positivity was almost half of CLART2 DNA positivity (29.7% vs. 55.5, p<0.001), significantly lower than HR DNA positivity (50.6%, p<0.001) and higher than HPV16 or 18 DNA positivity (20.1%, p<0.001)",36521,36733,True
1936284,11361,significantly decreased,Children treated with B. clausii had shorter duration of RI in comparison with the control group both during the treatment phase (mean 11.7 days vs 14.37; p=0.037) and the follow-up period (mean 6.6 days vs 10.92; p=0.049).,4131,4373,True
5777424,13842,significantly increase,"In regards to bleaching effectiveness, the bleaching procedure carried out in this study was able to significantly reduce the shade scores from the bleach guide,",35220,35381,True
4431716,12506,significantly decreased,"there were significant reductions with treatment as compared to usual care in cost (difference between study and control group: 1,586.01€; 95% CI 1,087.18 to 6,277.28; p<0.001)",8557,8733,True
5799986,13499,significantly decreased,The EndoIrrigator Plus group extruded significantly less debris than PUI and conventional syringe groups (P < 0.05),4484,4616,True
5777641,12480,significantly decreased,the participants in the experimental group reported significantly lower scores on the SCL-90,49341,49434,True
5860698,13550,no significant difference,the CVD risk strategy did not appear to be more beneficial than the SBP strategy,19435,19515,True
1994017,11662,significantly decreased,"In patients undergoing major orthopedic surgery, fondaparinux reduced the incidence of venous thromboembolism by more than 50% (p<0.001) compared with the low-molecular-weight heparin, enoxaparin",13120,13315,True
5388709,13426,no significant difference,"BA supplementation had no effect on voluntary or electrically evoked isometric force production, or twitch electromechanical delay and time-to-peak tension.",5921,6078,True
2921405,13777,no significant difference,Incidence of dysentery episodes was reduced by 21% (95% CI: 0 to 38%; p = 0.05),7067,7146,True
3717757,13822,no significant difference,"LR genotype persistent infections were non-significantly higher in the control (36.4%, 12/33) compared with the vaccine arm (22.1%, 15/68; p=0.13).",44283,44430,True
3671244,12382,significantly decreased,"The number of clusters that did not receive any referrals to community occupational therapy services was significantly higher in the control group at both 6 months (χ2 9,27; 1 ; p = .002)",34663,34861,True
5745479,13643,significantly increase,"a significantly higher proportion of any AE (diarrhoea or nausea or rash) was reported in the amoxicillin group compared to placebo (OR = 1.31, 95% CI 1.05–1.64)",12363,12526,True
1849920,13852,no significant difference,The amalgam and composite groups also did not differ significantly in the cumulative number of restored surfaces over the trial (p = 0.10).,21330,21486,True
5737953,13692,significantly increase,94.7% of patients treated with propolis and 68.4% of patients treated with aciclovir received efficacy assessments of “good” to “very good.” Differences were statistically significant at all visits,26111,26309,True
5805261,13748,no significant difference,"Ablation volume was not significantly different between SB-RFA and SM-RFA groups (61.8±24.3 vs.54.9±23.7 cm3, p = 0.229).",15832,15984,True
3524756,12702,no significant difference,Average population CVD risk decreased from 32.9% to 29.4% (p <0.001) in the NHS Health Check only group and from 31.9% to 29.2% (p <0.001) in the NHS Health Check plus additional lifestyle support group. There was no significant difference between the two groups,5685,5947,True
1578575,13570,significantly decreased,"In Group B (tamoxifen 10 mg/day), the mean percentage of nuclei stained by Ki-67 (MIB-1) was 24.69% before and 10.43% after tamoxifen treatment. Mean percentage of nuclei stained by estrogen receptor (1D5) was 59.53% before and 25.99% after tamoxifen treatment. Mean percentage of nuclei stained by progesterone receptor (PgR 636), was 59.34 before and 29.59% after tamoxifen treatment. A statistically significant reduction was found with the three markers (p < 0.001).",4687,5157,True
4588430,13577,significantly decreased,"Mean consultation times were 9.8 min (IQR 8 to 12.3) for telephone consultation, and 14.3 min (11.6 to 17.0) for face-to-face consultation with an estimated reduction (95% CI) of 4.3 (2.8 to 5.7) min in consultation times (p < 0.001)",5830,6064,True
5755346,12896,significantly increase,"Subjects completed a significantly greater amount of total work (m) during the 25-s treadmill sprint following ingestion of the MIPS compared to the PLA (MIPS: 93.97 ± 6.63; PLA: 93.01 ± 7.49 m, p = 0.039).",29808,30032,True
4173571,13542,significantly decreased,"A complete response (no PONV or RAE requirement) occurred in 88%, 76% and 44% in Group G, O and D respectively; P = 0.002",14632,14770,True
1821024,12153,no significant difference,"Ten metre walk time improved after treatment in both cases (median pre-treatment time for both groups combined 10.9 seconds, post-treatment 9.1 s, and 3 months later 9.6 s). There was however no difference between treatment groups.",5609,5840,True
3702091,13754,significantly increase,"the strength and endurance training had reduced the anxiety by 27% (P = .0001), depression by 37% (P = .0001) and C-reactive proteins by 20% (P = 0.0001), in the subjects.",5256,5478,True
3793517,13551,no significant difference,H. pylori eradication rates of sequential versus standard therapy were non-significantly different.,5080,5189,True
2826289,13488,significantly increase,"Subjects who received Bacillus coagulans GBI-30, 6086 experienced borderline statistically significant improvement in the Patient Pain Assessment score (P = .052) and statistically significant improvement in Pain Scale (P = .046) vs placebo.",4237,4530,True
5845721,13513,no significant difference,No significant differences in the number of days the nurses wore the activity monitor were observed between intervention groups (p > 0.05).,33338,33497,True
4218766,13491,significantly decreased,"In both genders zofenopril similarly reduced the 1-year risk of CV morbidity and mortality vs. placebo (−39% men, p = 0.0001; −40% women, p = 0.005).",6348,6497,True
4815896,13485,significantly decreased,increases in sICAM-1 levels (p = 0.0005) occurred in the placebo group (no increases in sICAM-1 in the MPT group),9757,9888,True
5827422,12840,significantly increase,Significant benefits of intervention were also found for class-wide measures of child behaviour including the level of appropriate child behaviour (ES = 0.73) and children's interest and enthusiasm (ES = 0.98),67704,67913,True
3668104,13752,no significant difference,"The heart rate and mean arterial pressure showed a decrease, but there were no significant differences among the three groups",13902,14027,True
5788508,12458,no significant difference,No significant difference was detected in terms of systolic and diastolic blood pressures and heart rate among groups prior to the induction of anesthesia.,5822,5977,True
3525031,13582,no significant difference,There was no difference between groups in terms of complications and supplementary analgesic use.,4833,4930,True
1208905,13622,no significant difference,"For all analyses, patients receiving true acupuncture reported slightly higher scores at follow-up, approximately equivalent to 10% of baseline. Patients in both groups improved, but no important differences between groups emerged",27920,28151,True
5388709,13428,significantly increase,"In fatigued muscle, post hoc analysis showed that HRT percentage change was significantly different between the BA (−25 ± 34 ms; −19 ± 26%) and PLA (8 ± 16 ms; 0 ± 15%) group with a large effect reported (P = 0.05, Cohen’s d = 0.9).",36331,36615,True
5852975,11970,significantly decreased,Increased optimism and control over the future	3.81 ± 0.55	4.27 ± 0.47	0.03,38124,38238,True
3661555,13812,no significant difference,Return-to-work rates were 86% and 83% (p = 0.6) for the intervention group and control group,7509,7602,True
4951149,13678,significantly decreased,The number of observed species (alpha-diversity) was significantly lower in the stools collected after the HCD (an average of 615 species) compared with those collected after the WSD (675 species) (P < 0.0001).,65538,65765,True
3872586,12551,significantly decreased,"intact tubes were detected in 3 cases in the transabdominal group and 18 cases in the transumbilical group (P < 0.001, OR: 51.0, CI 95%: 7.56-343.73).",15177,15344,True
4588672,13675,significantly increase,"At 12 weeks, the treatment group reported better subjective communication abilities (mini-CAL) than the no-intervention group (p=0.019)",8986,9122,True
1915628,11339,no significant difference,No differences were observed between the Mfb and EC group for outcome and subjects in both intervention groups showed comparable chances for improvement in pain intensity,3976,4147,True
4756971,13527,significantly decreased,The average VAS pain at 1 and 4 hours after the operation in the study group were significant lower in the control group (P≤0.001 and 0.026).,4278,4419,True
4757000,13587,significantly increase,Mean operation time was 24.25±3.41 (18–28) minutes in the TOS group and 16.30±1.65 (14–20) minutes in the single-incision sling group (p<0.05).,22318,22462,True
4173566,13278,no significant difference,mean arterial pressure did not show a significant difference.,5125,5187,True
4710520,13440,no significant difference,Diurnal IOP showed no difference between the groups,5834,5886,True
5845829,12843,no significant difference,No difference was seen in PD-1 expression on CD8 T cells among the groups,25087,25160,True
4390525,13882,significantly decreased,The best results of saphenous nerve regeneration were observed in G4 (one out of 20 patients – 5% in both IC–SD and FvF studies) and the worst in G1 (seven out of 20 patients – 35% in IC–SD examinations and nine out of 20 patients – 45% in FvF studies) groups,30321,30580,True
4390525,13882,significantly decreased,"Differences between groups	G1:G3 = 0.0103	G1:G2 = 0.0224	G1:G2 = 0.0309	
G1:G4 = 0.0248	G1:G4 = 0.0007	G1:G4 = 0.0084",29290,29711,True
4161888,12280,no significant difference,Mortality rates at 28 and 90 days did not differ between groups:,6605,6670,True
4161875,13699,significantly decreased,A significant reduction in daily nursing workload for glucose control was found in the intervention group (17 versus 36 minutes; P <0.001).,6140,6296,True
5446277,13087,no significant difference,"There were no differences in comprehension score (16.8 ± 5.7 v. 16.3 ± 3.5), subjective understanding (median 6.0 v. 6.5), or overall satisfaction with consent (median 7.0 v. 6.5) between control and intervention groups (all p>0.50).",4698,4932,True
1851720,11650,no significant difference,There were no significant differences in the cognitive function scores between the two arms,34131,34222,True
3634264,13833,no significant difference,"This study showed that after one month of L-carnitine or placebo therapy there was no significant improvement in flow mediated dilation (p = 0.80 and p = 0.59, respectively) or decrease in carotid intima-media thickness (p = 0.12 and p = 0.50, respectively).",4849,5107,True
3398966,13891,significantly decreased,"Overall, 86 (9.9%) intervention participants and 111 (12.9%) control participants died during the study period, representing a 25% lower relative risk of death (unadjusted hazard ratio [HR] 0.75 [95% CI 0.57–1.00], p = 0.047) among the intervention group",84919,85190,True
3580671,12418,significantly increase,Microbiological success rate was higher in the Infusion group as opposed to the Bolus group (90.6% vs. 78.4%; P = 0.020).,5795,5934,True
4733100,13793,no significant difference,ntervention participants had significantly increased odds of meeting ≥ 150 min/week of moderate-equivalent physical activity at 6 months (OR = 6.26; 95% CI: 1.26–31.22; p = 0.03) and borderline significantly increased odds at 12 months (OR = 4.73; 95% CI: 0.98–22.76; p = 0.053).,5858,6137,True
4236282,11770,no significant difference,NPC BDI scores at post-treatment assessment were significantly lower when compared to UC (p=0.009) but not MIC (p=0.195).,26213,26368,True
3664320,13666,significantly increase,The objective response rate was 52.0% for axitinib and 3.4% for sorafenib (P = 0.0001).,7631,7736,True
4173571,13545,no significant difference,"Post-operative sedation (Grade 2 and 3) was observed in 20%, 44% and 20% of patients in Group G, O and D respectively; P = 0.092",16528,16673,True
3646875,13854,no significant difference,"the ontologies developed after specific training were only slightly but not significantly closer to the gold standard ontologies than the ontologies developed without prior specific training; (b) although significant differences for certain ontologies were detected, the intra-group similarity was not consistently influenced in one direction by the differential training.",7567,7940,True
5753932,13888,significantly increase,Exercise in cooler room temperature increased maximum voluntary contraction force (p = 0.010),5926,6037,True
5827033,12001,significantly decreased,"Time to nasogastric tube removal in the TEA group was earlier than in the control group (4.22 ± 1.01 vs 4.97 ± 1.67 d, P = 0.049),",7618,7782,True
5976899,13797,no significant difference,"Comparing the gains of the participants in the two groups indicated that pain, NDI, right/left neck rotation, left lateral flexion ROM, and mental health subcategory of SF-36 had similar improvement rate in both groups (p > 0.05) (",18570,18818,True
4757000,13584,significantly increase,"subjective cure rates were found higher in TOS group (75% versus 55%, p=0.190).",5207,5287,True
5789502,13614,significantly decreased,"the difference in HRs was significantly lower in Group D0.3 from 5 min till 15 min of the surgery (P < 0.05),",4560,4709,True
3580299,12409,no significant difference,Thirty-nine of 41 (95.1%) patients in group 1 and 40 of 43 (93.0%) patients in group 2 ultimately passed stones (p=0.96),4577,4697,True
5435086,13817,significantly decreased,"There was a total of 35 and 66 severe exacerbations in the SMART and Standard groups respectively; relative rate (95% CI) 0·54 (0·36 to 0·82), P = 0·004.",25930,26101,True
5777419,13505,significantly decreased,"Compared with baseline, there was a significant reduction in the probiotic group at 6-month follow-up, while for the antibiotic group it occurred at all times (p<0.017).",46321,46490,True
5599826,13425,significantly increase,AR group also showed meaningfully (p<0.05) improved results in morse fall scale.,11920,12000,True
4756971,13530,significantly increase,the first analgesic demand were significantly lower and longer in study group.,4483,4562,True
4717613,13512,significantly decreased,The mean chest tube drainage time was 6 (1–42) days in the control group against 4 (2–15) days for the nutrition program group (p = 0.019).,5624,5780,True
5799931,11883,significantly decreased,Significantly a higher number of blastocysts were obtained in Group B than Group A (4.00 vs. 3.04; P = 0.023).,5870,6000,True
4736250,13887,significantly increase,"Significant differences were observed between groups at post-test for the fibre intake score (p = 0.004), fat intake score (p < 0.001), fruit intake (p = 0.001), and vegetable intake (p < 0.001).",34571,34837,True
1849920,13851,no significant difference,he amalgam and composite groups also did not differ significantly in the cumulative number of restored surfaces over the trial (p = 0.10),21331,21485,True
3666925,13710,significantly increase,". Morphine-induced postconditioned patients had lower peak inotropic score (5.7 ± 2.4 versus 8.4 ± 3.6, p<0.0001) and shorter duration of mechanical ventilation as well as ICU stay (20.6 ± 6.8 versus 28.5 ± 8.3 hours, p<0.0001 and 40.4 ± 10.3 versus 57.8 ± 15.2 hours, p<0.0001, respectively), while higher left ventricular ejection fraction as well as cardiac output (0.57±0.15 versus 0.51±0.13, p=0.0467 and 1.39 ± 0.25 versus 1.24 ± 0.21 L/min, p=0.0029, respectively) as compared to the control group",5518,6023,True
5827422,12842,significantly increase,"Significant benefits of intervention were found for teachers’ positive [effect size (ES) = 3.35] and negative (ES = 1.29) behaviours to the whole class and to high-risk children (positive: ES = 0.83; negative: ES = 0.50) and for observer ratings of class-wide child behaviour (ES = 0.73), child interest and enthusiasm (ES = 0.98), teacher warmth (ES = 2.03) and opportunities provided to share and help (ES = 5.72).",5298,5715,True
3661555,13815,no significant difference,Work functioning and costs did not differ statistically between groups,7980,8051,True
3474775,11808,significantly decreased,"Participants randomized to lisinopril vs. L-placebo had significant declines in diastolic BP (−3.3 mmHg, p = 0.05), hsCRP (−0.61 µg/mL, p = 0.02) and TNF-α (−0.17 pg/mL, p = 0.04).",8303,8484,True
1887535,11250,significantly decreased,"On day-21, gametocyte prevalence in SP group was significantly higher than the two combinatory treatments (AQ+SP and AQ+AS).",29257,29381,True
3931289,13623,no significant difference,There was no significant difference in time to first pulmonary exacerbation (log rank test p = 0.3169).,5114,5217,True
1887535,11254,no significant difference,"ACPR to AQ, SP, AQ+SP and AQ+AS did not differ significantly on day-14 or day-28 (PCR-uncorrected and -corrected).",20626,20740,True
5789504,12484,significantly decreased,The mean time taken to intubate with Macintosh laryngoscope was 50.34 ± 26.76 s whereas with C-MAC D-Blade time taken was 39.56 ± 15.65 s in Group C (P < 0.05) and is statistically significant,16470,16680,True
5799986,13500,significantly decreased,PUI group extruded significantly less debris than conventional syringe irrigation group (P < 0.05).,4630,4750,True
1977297,11639,significantly increase,"When these same histological characteristics were used to compare survival, the capacity to separate invasive cancers into two groups having good and poor survival probabilities was evident, with a significant improvement for the screen detected poor survival group compared with controls (P less than 0.05).",3191,3499,True
32174,11172,significantly decreased,"PHR group patients were more satisfied with the recovery they had made (79% vs. 59%, p=0.04), but felt less able to talk to staff about their problems (61% vs. 82%, p=0.02)",4735,4908,True
1888710,11325,,no comparison between girls groups,-1,-1,False
4733100,13792,significantly increase,intervention participants had significantly increased odds of meeting ≥ 150 min/week of moderate-equivalent physical activity at 6 months (OR = 6.26; 95% CI: 1.26–31.22; p = 0.03),5857,6036,True
5741924,12313,no significant difference,"There were also no differences between the two groups in mean gestational weight gain, gestational diabetes, birth weight, infant length, and head circumference.",8693,8854,True
1693563,11416,no significant difference,"Placebo injection had no significant (p > 0.05) effect on the forced expiratory spirogram, heart rate, minute ventilation (Ve), or respiratory sensation. Similarly, adenosine injection caused no significant changes (p > 0.05) in the forced expiratory spirogram;",3650,3912,True
5812877,11841,significantly increase,"Participants' skin temperature, tympanic temperature, body weight changes, heart rate, ratings of perceived exertion, and plasma volume changes were significantly higher (p < 0.05) in the hot trial compared to the cool trial",5618,5859,True
59899,11375,no significant difference,No postoperative morbidity or mortality occurred in either group.,4429,4494,True
3635594,13618,significantly decreased,"MSF treatment accumulated significant AChE inhibition as compared with control (F(1,8) = 212.000, P < 0.001)",31979,32133,True
5561409,11821,no significant difference,"For spindle frequency activity, theta, beta1, and beta2 activity, no statistical differences were observed.",20120,20227,True
2797956,13603,no significant difference,"A trend to better control was observed only from 2200 to 200 during closed-loop phases (6.2 ± 0.4 vs. 7.9 ± 0.9 mmol/l, P = 0.069",28476,28622,True
5498708,12861,significantly increase,"Response to treatment (a reduction of at least 25% in the signs) in the group taking methylphenidate plus PUFA was 90% (18 patients) and in methylphenidate plus placebo group, it was 60% (12 patients) (p=0.028).",5197,5408,True
3636850,13636,no significant difference,No significant difference was seen in DMFT and deft between the fluoridated and non-fluoridated groups,4397,4500,True
3661336,11833,significantly increase,The t-test revealed a significant difference of the mean fitness increases between experimental and control groups (p = 0.03).,31176,31320,True
5827507,13673,significantly decreased,"Synergistic use of 5% KNO3 and diode laser (Group 3) significantly reduced the DH pain,",4563,4662,True
3757635,13564,significantly decreased,"The median surgical time was statistically significantly lower at 11 min (range 9 min to 15 min) in the glue group, compared to 21 min (range 12 min to 28 min) for the suture group (P < 0.05).",3827,4039,True
3493722,11906,no significant difference,"There was no significant difference in the eradication rate, patient compliance or rate of adverse events between the two groups.",7427,7557,True
4497726,12253,significantly increase,"Within the 3 exercising groups, AE were more common (X2[2] = 11.3, p = 0.003) in individuals exercising at 150min/wk (n = 40, 35 mild) and 225 min/wk (n = 36, 34 mild) than 75 min/wk (n = 15, 15 mild).",48998,49266,True
5781264,12160,significantly increase,"Significantly greater energy (mean (SD) 1712 (511) calories vs. 1130 (601) calories, p < 0.0001) and proportion of estimated energy requirement (mean (SD) 83 (25) % vs. 53 (29) %, p < 0.0001) from EN and/or PN was delivered to the intervention group compared to usual care.",13353,13664,True
5822856,13535,no significant difference,"Insole wearing time was 6 h/day (±2.4, 2.2–12) in G1 and 6.2 h/day (±2.7, 1.9–12) in G2. No significant difference was found between groups (p=0.91).",20437,20604,True
4021157,12657,no significant difference,Differences between the three groups in the level of state anxiety as measured by the STAI at each of the time points were very small and not statistically significant,36241,36409,True
3478157,12369,significantly increase,"In subjects receiving VXP, the IIEF-Erectile Function (EF) scores improved significantly as compared to placebo.",5265,5378,True
5055753,13481,significantly decreased,Those administered fentanyl in the clonidine group 105 ± 30.8 was significantly lower than that for the midazolam group 165 ± 34.5 (P = 0.0018). T,5129,5276,True
5629746,12442,no significant difference,"The PaCO2 values were similar between the two groups (p=0.591,",17347,17438,True
5629746,12445,significantly decreased,"Discomforts related to the interface and symptoms of airway dryness were significantly lower in the HFNC group than those in the air entrainment mask group [3(3-4.5) vs. 7(6-8); 3(2-3.5) vs. 5(4.7-6), both p<0.001]",17863,18128,True
5976949,12886,significantly increase,leptin/adiponectin ratio (LAR) was increased in GDM2 compared to controls and GDM1 (p = 0.038) and did not differ between GDM1 and controls,6321,6481,True
5557991,11781,significantly increase,following ketamine administration compared to midazolam (P=0.002); movement of children decreased with fewer incidence of treatment interruption (P=0.001) while their sleepiness increased (P=0.003).,4569,4767,True
34114,11668,significantly decreased,The data suggest a statistically significant reduction in the number of tender joints (P < 0.008),6810,6926,True
5976307,13097,no significant difference,"Sedation-related outcomes such as induction time (P = .833), total procedure time (P = .111) and awake time (P = .070) were not different",20276,20466,True
4210953,13459,no significant difference,"there were no statistically significant differences between intervention and control groups on treatment completion, treatment length, number of sessions attended, or DNA rate.",29289,29466,True
5866733,13629,significantly decreased,"the differences in NH3 levels were significant after cardiopulmonary bypass (37.8±10.26 vs. 47.0±14.57, for Group 1 and 2, respectively, p<0.05, unpaired t test), at 24th hour (39.0±8.80 vs. 55.4±19.64, for Group 1 and 2, respectively, p<0.05, unpaired t test) and at 48th hour (40.1±8.44 vs. 53.2±20.15, for Group 1 and 2, respectively, p<0.05, unpaired t test)",15038,15537,True
4525725,13498,significantly increase,"Participants were significantly more likely to agree that the tailored feedback was ‘relevant to me’ compared to the generic feedback, Fisher’s exact: χ2(1, N = 87) = 5.22, p = .03,",26472,26716,True
2826289,13489,no significant difference,There were no significant differences in the physician global assessment or physician assessment of painful and swollen joints.,17196,17324,True
4028193,13766,significantly increase,"The iCBT program showed a significant effect on BDI-II (t = −1.99, p<0.05).",44472,44547,True
4589005,12850,significantly decreased,DSG 1% treatment also resulted in significantly greater reductions in ankle swelling than placebo.,5082,5182,True
1847837,11588,no significant difference,"No significant differences in lung function (active-placebo) were found (Forced Expiratory Volume in 1 second: mean difference [95% CI] = 0.01 [-0.12 to 0.14] L, p = 0.9. Peak Expiratory Flow: -4.08 [-35.03 to 26.89]. L/min, p = 0.8).",4794,5028,True
5440036,13436,significantly increase,Fewer patients in Group P2.5 did not experience any nausea or vomiting throughout the study (49%) compared with those in Group P7.5 (67%) and Group P+D (81%; P<0.01).,5067,5253,True
3474842,12540,no significant difference,"Deaths, hospitalisations and pneumonia were non-significantly reduced in the T&P allocated facilities.",10303,10406,True
5812877,11843,significantly increase,"Participants' skin temperature, tympanic temperature, body weight changes, heart rate, ratings of perceived exertion, and plasma volume changes were significantly higher (p < 0.05) in the hot trial compared to the cool trial.",5618,5860,True
3636944,12624,,no statistical comparison,-1,-1,False
5827042,13637,significantly decreased,". Out of the 9 patients who experienced treatment failure, 8 (88.90%) patients were in dexmedetomidine group and 1 (11.10%) was in the midazolam group (p = 0.029).",15201,15365,True
3687098,13568,no significant difference,"For the composite endpoint of pancreatitis (which included the MedDRA terms “pancreatitis” and “pancreatitis acute”), the incidence rates were similar for both groups",45662,45829,True
4710520,13444,no significant difference,Diurnal OPP and DOPP also showed no statistically significant difference between the groups,6133,6225,True
5758845,13251,no significant difference,"systolic blood pressure (SBP), diastolic blood pressure (DBP), pulse, AST, ALT, blood urea nitrogen (BUN), and creatinine did not show significant difference between SJDBT group and placebo group",21286,21483,True
1968524,11402,significantly increase,The median WHO score for haematological toxicity was 4 for bolus therapy and 3 for CI therapy (P = 0.0007,2496,2602,True
5851005,12916,significantly increase,A CR was achieved by 80.0% in the aprepitant group compared with 56.0% in the standard group during the OP (P =0.018),6229,6346,True
5096778,13869,no significant difference,"When CM participants were on ibudilast treatment, they did not experience reduced frequency of moderate to severe headache compared with placebo treatment (P=0.9)",23871,24051,True
3769981,12769,significantly increase,Increases from baseline in serum calcium were observed for the paricalcitol 1-μg/day (0.16 mg/dL; P = 0.039 versus placebo) and 2-μg/day groups (0.48 mg/dL; P < 0.001 versus placebo),24427,24610,True
5791430,12722,no significant difference,"there was no significant difference in mean total age (P = 0.23), working experience (P = 0.12), and working hours of the nurses (P = 0.41),",15875,16066,True
5769198,12113,no significant difference,"Mental health scores showed significant improvement between groups after 5 years (P = 0.058) with YLSP group showing better results than CLSP group. There was nonsignificant change in YLSP group (3.20%, P = 0.203) and in CLSP group (−2.09%, P = 0.640) after 5 years.",19965,20282,True
3714284,12191,no significant difference,"There was no evidence of statistically significant protection against HPV31, 51, 52, 56, 39, or 6/11(",58087,58188,True
3666914,12716,significantly increase,"The majority, 68.7% in the intervention group no longer met ICD-10 criteria for depression on the CIS-R (‘recovered’) compared to 38.5% of those receiving usual care",38140,38306,True
3666914,12716,significantly increase,"continuous CIS-R mean scores were lower for the intervention group compared with the usual care group at 15 weeks post-randomisation. After adjustment for baseline CIS-R score and the 4 key design variables (age, depression severity, current symptom duration and history of depression), the intervention group had a mean CIS-R score that was 10 points lower than those in the usual care group at 15 weeks",44509,44914,True
5732507,13769,no significant difference,"There were no significant differences between SC and EI on infant HIV status at 6 weeks and at 12 months,",9678,9785,True
2365957,13452,no significant difference,"CD4+ counts showed a similar pattern of increase over the course of the study in the FPV/r100 and ATV/r100 arms, with no statistically significant differences in magnitude of CD4+ count increase at any study visit",23528,23741,True
3751568,13849,significantly increase,"Significant differences between treatment groups were noted for parent-reported overall psychosocial health (p=0.009), specifically self-esteem (p=0.034), mental health (p=0.001) and behaviour (p=0.019), in favour of exercising into the hypermobile range (n=11) compared to neutral only (n=14).",6025,6319,True
3494227,13517,significantly decreased,"There were significant reductions in anxiety (P<0/001), depressive (P<0/001) and worry symptoms (P<0/001) from baseline to end of treatment.",4817,5014,True
3659039,12556,significantly increase,"Plasma PC DHA did not change significantly in the control group (P > 0.05; Figure 1). Plasma PC DHA increased in the treatment group (P < 0.001),",18478,18671,True
3636954,12293,significantly increase,The mean change in alveolar crest level between control and experimental groups was significant (P=0.02).,4879,5001,True
4511442,13212,no significant difference,"When we compared the two weaning groups, we found no significant difference in the Pimax (p =0.270) and Pemax (p =0.058) measured before the SBT. There was also no significant difference between the two groups concerning the FVC or the RSBI",24427,24720,True
1913939,13523,no significant difference,"Subjects using the Web-based program performed significantly better than the print group on Attitudes Toward a Healthful Diet (F1,415 = 7.104, P = .008) and Dietary Stage of Change (F1,408 = 6.487, P = .01), but there were no significant group differences on the five other dietary measures.",5747,6094,True
4733105,13606,significantly increase,"Group V showed the greatest increase in high‐gamma power in the left MFG from 100 to 200 msec in the target condition. In addition, Groups V and P showed increased high‐gamma power compared to Group C (which exhibited decreased high‐gamma power) in the left thalamus from 0 to 100 msec and from 200 to 300 msec in the nontarget condition",49966,50303,True
5809707,11685,no significant difference,"There were also no differences in the incidence of desaturation (P = 0.922), hypotension (P = 0.880), coughing (P = 0.269), or hiccups (P = 0.727) among the three groups",16164,16334,True
4771973,11996,significantly decreased,"The metformin group gained less weight (between-group difference −2.6 kg (95% CI −3.3 to −1.8), p<0.001).",12673,12779,True
1915612,11321,no significant difference,"After 12 weeks there was no significant difference between the two treatment groups in decrease of neck pain intensity on VAS (−7.0 mm, 95% confidence interval (CI) [−20.7 to +6.7]), mean number of neck pain days (−1%; 95% CI [−15% to +13%]), neck pain hours per day (−0.14; 95% CI [−3.0 to +2.7]",3212,3508,True
5850777,12615,no significant difference,"In the intention-to-treat (ITT) population, the mean (SD) number of oocytes retrieved (primary endpoint) was 3.3 (2.71) in the r-hFSH/r-hLH group compared with 3.6 (2.82) in the r-hFSH group (between-group difference not statistically significant).",8072,8320,True
3525331,13141,significantly decreased,"Compared with the placebo group, the CXDT-HFG group showed significant reduction in migraine days and attacks frequency at week 12 and follow-up period (P < 0.05)",7461,7640,True
3682309,13845,no significant difference,"Mean RRT dose, mL/kg/hr	33.6 ± 7.4	34.7 ± 4.4	0.50",31104,31217,True
3664406,13559,significantly increase,Mothers were more likely to state that using a bathing product left their neonate smelling good (p < .001).,58265,58389,True
5729492,12665,no significant difference,"There was no significant difference in BMI changes (%) from baseline to the end of the study between the control and feedback groups (−0.3 [4.6] vs. 0.04 [4.8]; 95% CI, −1.7 to 1.2).",36200,36383,True
5873437,13591,significantly decreased,Fewer ELAD subjects had positive postdischarge PEth than controls (28% versus 52%; P < 0.05).,81535,81646,True
3793517,13552,no significant difference,Serum ferritin non-significantly differed between the two therapy groups,5189,5262,True
3636841,12305,no significant difference,"no statistical difference was seen in microbial growth, total bacterial count, and lactobacilli count in both the groups (P = 0.36).",3670,3819,True
5986513,12648,no significant difference,". There was no difference between high and standard HMF groups for weight gain (mean difference (MD) −14 g/week; 95% CI −32, 4; p = 0.12), length gain (MD −0.01 cm/week; 95% CI −0.06, 0.03; p = 0.45) or head circumference gain (MD 0.007 cm/week; 95% CI −0.05, 0.06; p = 0.79),",5226,5553,True
3669033,12808,significantly increase,"Stress hormone profile (salivary cortisol and testosterone) was significantly improved by TA supplementation, with reduced cortisol exposure (−16%) and increased testosterone status (+37%).",4459,4648,True
5093191,13788,significantly decreased,"A significant difference (unadjusted for multiplicity) in favour of men in the intervention was also found for resting heart rate (M diff = −3.76 beats/min, p = 0.034).",5509,5723,True
4745915,13838,no significant difference,"no differences in the course of the 12-week time period could be detected between the patient groups for the absolute number of CD80+ and CD86+ cDC,",35090,35261,True
1522015,13518,significantly increase,"The mean log retinal area when the participants were on lutein was 0.018 higher (95% CI: 0.001, 0.036, p value: 0.038) than when they received placebo,",35228,35381,True
1794625,11216,no significant difference,"VAS scores (scale 0–10) indicated a trend towards increased patient satisfaction while using APAP with C-Flex (7.9 vs 7.2, p = 0.07)",4291,4440,True
3782125,12243,no significant difference,There was no significant difference in the patterns of NRT use between subjects in the A1 and A2 groups,22062,22165,True
3781573,13576,significantly decreased,"HbA1c was significantly lower in the IS strategy arm than in the IP strategy arm, and this difference was maintained through study end (7.1 ± 1.4 vs. 7.6 ± 1.4% in IS vs. IP at year 4, P < 0.01).",22016,22239,True
5745479,13645,significantly increase,"A significantly higher proportion of any AEs (diarrhoea or nausea or rash) (OR = 1.31, 95% CI 1.05–1.64, number needed to harm (NNH) = 24) and of diarrhoea (OR 1.43 95% CI 1.08–1.90, NNH = 29) was reported in the amoxicillin group during the first week after randomisation.",7113,7387,True
1821028,11432,significantly increase,HDL-cholesterol was increased by 10.02 mg/dl (P-value: .000).,20319,20380,True
5822856,13533,significantly increase,"A significant improvement was noted after 4 weeks in both G1 and G2 (p<0.0001), but not in CG",20003,20114,True
5827042,13638,significantly increase,dexmedetomidine group had a significantly shorter time to recovery (p < 0.001).,15675,15754,True
2797957,13879,no significant difference,"there was no difference in mean change in superficial (P = 0.72; 9.1; −15.3 to 21.93), deep (P = 0.38; 10.5; −12.2 to 30.8), and muscular (P = 0.26; 10.3; −9.15 to 33.0) pain VAS.",8572,8803,True
3474842,12537,significantly decreased,The policy of T&P resulted in a significant reduction in the influenza attack rate amongst residents: 93/255 (36%) in residents in T facilities versus 91/397 (23%) in T&P facilities (p = 0.002),9876,10069,True
3647148,12250,no significant difference,"Comparing the 36 retinol-allocated versus 36 control blocks in analyses of the primary outcome, deaths per child-care centre at ages 1·0–6·0 years during the 5-year study were 3·01 retinol versus 3·15 control (absolute reduction 0·14 [SE 0·11], mortality ratio 0·96, 95% CI 0·89–1·03, p=0·22),",5965,6259,True
5741948,13730,no significant difference,"There were no differences in adjusted health and social care costs (£95, 95% CI -£1410 to £1599) or societal costs (£675, 95% CI -£1039 to £2388) between the intervention and control arms.",13921,14109,True
3661555,13813,no significant difference,Median time from initial sick leave to partial return-to-work was 194 days (range 14–435) versus 192 days (range 82–465) (p = 0.90),7687,7818,True
5827475,12474,significantly increase,"Significantly higher PIP was recorded with I-Gel™ than PLMA during maximum flexion (17.7[4] vs. 14.6 [2.4] cm H2O, P = 0.001)",15971,16164,True
5985618,13755,significantly increase,"Pain levels in Group A were greater than in Group B at all time points, and the differences between the two groups were statistically significant (P<0.05).",18775,18930,True
3474778,13782,significantly increase,"The quality of water stored in intervention households was significantly better than in control households (3 vs. 181 TTC/100 mL, respectively, p<0.001).",7142,7319,True
5862001,13414,significantly increase,"Smoothness indexes and treatment-on-variability indexes were significantly (P = 0.0001) higher under olmesartan dual (1.53/1.22, 1.67/1.29, 2.05/1.59), olmesartan triple (2.47/1.85, 2.80/2.06, 3.64/2.67), or active control dual combination (1.70/1.26, 1.85/1.33, 2.29/1.65) than under monotherapies (control: 0.86/0.73, 0.80/0.65, 1.01/0.82; olmesartan: 1.02/0.86, 0.95/0.78, 1.23/1.00).",5695,6100,True
3931289,13624,no significant difference,"there was no significant difference between groups in exacerbation rate during the study period (2.04 exacerbations per person year in esomeprazole group 95% CI (1.33, 4.14) compared with 0.59 exacerbations per person year in placebo group (95% CI (0.19, 1.82), p = 0.07.",22287,22558,True
3409545,13532,no significant difference,"Within group, comparison of the treatment results revealed that both conditions were associated with a statistically significant changes in salivary cortisol, negative affect, positive affect, and pain (P < .05),",17449,17679,True
3409545,13532,no significant difference,"According to between-group  t-tests, no significantly greater improvement in outcomes resulted when the two treatment conditions were compared.",18010,18170,True
3757635,13563,significantly decreased,The medians of the visual analogue scale values were significantly lower in the glue group (P < 0.05),3707,3825,True
5066860,13455,significantly increase,"After the NUT period, participants showed a significant reduction in MRS score (18.4±5.4) in comparison to baseline (28.4±5) and the placebo period (28±5.2) (P<0.0001 for both comparisons). Furthermore, at the end of the active-treatment period, we observed a significant reduction in triglycerides, total and low-density lipoprotein cholesterol plasma levels and an increase in high-density lipoprotein cholesterol plasma concentration versus baseline and versus placebo (all P<0.04).",5285,5807,True
1079844,11826,no significant difference,there were no significant differences between the treatment groups in the numbers of deaths from all cancers or from cancers at particular sites,37663,37808,True
4469426,12400,no significant difference,"Endothelial function was evaluated plasma E-selectin, VCAM-1, and NO. E-selectin and NO levels were not affected by either diet.",38723,38852,True
5773984,12621,significantly decreased,"It was found that the mean time taken for implant placement in Group A (13.34 ± 1.95) was less than the mean time taken for implant placement in the Group B (17.50 ± 2.24), which was highly significant (P = 0.048)",14429,14659,True
2365983,13716,no significant difference,"Morbidity and reoperation rates in the total laparoscopic, hand-assisted laparoscopic, and open groups were comparable (29 vs. 20 vs. 23 percent and 17 vs.10 vs. 13 percent, respectively)",4707,4966,True
4358417,13611,significantly decreased,"Abdominal total fat area, abdominal visceral fat area, body weight, and body mass index decreased significantly in the rosehip group at week 12 compared with their baseline levels (P<0.01) after receiving the rosehip tablet intake, and the decreases in these parameters were significantly higher when compared with those in the placebo group.",4946,5305,True
4733222,12652,significantly increase,mean average weekly compliance was significantly greater for participants in ePaper conditions (mean [SD] 0.91 [0.2]) than for those in Mobile conditions (mean [SD] 0.39 [0.38],43285,43462,True
4681166,12812,no significant difference,No systematic effects of the interventions were found for serum lipids.,5869,5940,True
5809707,11686,no significant difference,There was no difference in operator feasibility in the groups as rated by the endoscopist (P = 0.595),16724,16826,True
3258215,13460,no significant difference,"Of the 37 pharmacies in the intervention group, 17 pharmacies (50%) provided EAFD and 12 pharmacies (35.3%) provided EASD compared to 14 pharmacies (45.2%, P = 0.715) and 12 pharmacies (38.7%, P = 0.899), respectively, of the 34 pharmacies in the control group.",4895,5191,True
5856421,12923,no significant difference,The duration of surgery did not significantly differ between the groups (67.3 vs. 64.3 mins; p = 0.30).,6735,6839,True
3685779,12074,no significant difference,Within group differences in interleukin 6 and F2-isoprostane only for group 1 was marginally significant (P<0.1).,13263,13396,True
1177952,11245,no significant difference,There were no differences between the two groups in the time course or magnitude of CK-MB release: the peak CK-MB level was 249 ± 228 U/L in the GIK group and 240 ± 200 U/L in the control group (NS).,6376,6576,True
5755650,13389,no significant difference,Systolic and diastolic blood pressure decreased significantly in both groups,18592,18668,True
5807510,13720,significantly increase,"Among infants enrolled in the first 25 days of life, the rate of neonatal diagnosis was higher in cases (32%, 7 of 22) than controls (0%, 0 of 23; difference, 32% [95% CI, 11–53%];p = 0.004).",10199,10408,True
3532083,12056,no significant difference,"partially reflecting similar recurrence rates (10% for 4LB and 13% for SSB at 52 weeks, data not shown)",36613,36716,True
5827507,13674,no significant difference,"ly, the mean differences for (a) Group 1 (5% KNO3)–Group 4 (placebo) and (b) Group 2 (diode laser)–Group 3 (synergistic application of 5% KNO3 and diode laser) were insignificant for any of the tests (P > 0.001)",20170,20398,True
1950208,11571,no significant difference,"On average, by the age of 4 y, children will have had 1.12 (95% CI: 0.97 to 1.28) episodes of anaemia with a PCV of <25%; nearly half these episodes are in children aged less than 1 y (Table 1). This corresponds to an incidence rate of 0.77 episodes/PYAR.",31831,32144,True
3669033,12805,significantly decreased,"Significant improvements were found in the TA group for Tension (−11%), Anger (−12%), and Confusion (−15%).",4351,4459,True
1913939,13524,no significant difference,The ANCOVA to test differential change between the Web group and the print group detected no differences between the two groups on the three measures of stress,44750,44909,True
4756971,13528,no significant difference,"The postoperative VAS pain at 4, 12, 24 and 48 hours were not significantly different between both groups.",18998,19105,True
5827476,13549,no significant difference,"There was no significant difference in incidence of shoulder pain, nausea and vomiting between the groups",4792,4897,True
5789501,13764,no significant difference,"Both the groups showed statistically similar improvement of VAS, range of motion and SPADI at 4-week (P > 0.05) follow-up.",4830,4973,True
2921405,13778,significantly decreased,Incidence of pneumonia was reduced by 24% (95% CI: 0 to 42%; p = 0.05) and severe acute lower respiratory infection (ALRI) by 35% (95% CI: 0 to 58%; p = 0.05).,7147,7307,True
5642889,13301,no significant difference,"The use of therapeutic uterotonics was higher in the control group, but there was no significant difference between groups (39.5% vs. 50.6%, respectively, RR = 0.79, 95% CI = 0.58–1.09)",48898,49083,True
4364332,13722,significantly increase,"The £100 incentive offer increased positive response to the first invitation letter from 24.7% to 31.6%, an increase of 6.9% (P < 0.05)",5155,5307,True
3525331,13142,significantly decreased,"Compared with the placebo group, the CXDT-HFG group showed significant reduction in migraine days and attacks frequency at week 12 and follow-up period (P < 0.05)",7461,7641,True
5561588,13617,significantly increase,"maximum block was recorded slightly later at the adductor pollicis muscle compared to the trapezius muscle: 2.8 ± 1.1 versus 2.5 ± 1.1 min, respectively, (mean ± SD; P = 0.006)",22369,22562,True
5055753,13480,significantly decreased,"the percentages of patients in the agitated and heavily sedated group were significantly higher in the midazolam group, compared to this in the clonidine group (P = 0.002 and 0.014; respectively)",18661,18856,True
2556743,13429,significantly increase,"the amount of HES and the total amount of fluid (including crystalloid, HES, and blood products) was significantly greater in group I than in group C (Table 2).",21488,21687,True
3681405,13680,significantly decreased,"the median survival time (MST) in the preoperative chemotherapy arm was lower than that of surgery-alone arm (MST, 45.42 months vs 57.59 months) (P = 0.016).",4522,4698,True
3695249,13536,significantly decreased,"Six patients (17.1%) in the ondansetron group, 5 (14.3%) in the ramosetron group, and none (0%) in the palonosetron group (P = 0.041) requested disconnection of the IV-PCA pumps because of intractable nausea and/or vomiting after surgery mostly within 12 h.",16535,16792,True
3682309,13847,no significant difference,"Net ultrafiltration, L/day	1.7 ± 2.2	0.8 ± 4.1	0.98",31399,31513,True
1578590,11410,significantly decreased,Beta-blocked patients who received early atropine (Group A&B) had a significantly lower double product (p = 0.008),4832,4946,True
3680603,13745,no significant difference,"no statistical significant differences were observed between the two groups in the duration of mechanical ventilator support, ICU stay, chest tube drainage for postoperative 6 hours, chest tube indwelling time, hospital stay, transfusion amounts, or postoperative complications (p>0.05) (",15369,15657,True
3261693,12164,significantly increase,Mean improvement in VA was significantly greater in implanted than non-implanted eyes at 1 (P = 0.0047) and 3 months (P = 0.0015),4336,4500,True
4748323,11775,no significant difference,"Post hoc analysis revealed a significantly larger effect in favour of the high-adherence group compared to the control group for fall risk (p = 0.031), postural sway (p = 0.046), stepping reaction time (p = 0.041), executive functioning (p = 0.044), and quality of life (p for trend = 0.052).",8895,9255,True
5822859,13836,no significant difference,"Mean FOPI in IUGR fetuses (n = 15) was 3.70 ± 0.99 (3.15–4.26); in the group II (n = 12), it was 2.84 ± 0.69 (2.40–3.28), and in the group III (n = 13), it was 2.77 ± 0.44 (2.50–3.04) (p=0.004)",6511,6772,True
2556743,13431,significantly decreased,"The number of postoperative complications per patient (1.4 ± 2.1 versus 3.9 ± 2.8, P < 0.05), as well as the median duration of mechanical ventilation (1 versus 5 days, P < 0.05) and stay in the intensive care unit (3 versus 9 days, P < 0.01) was also lower in group I.",5291,5620,True
5561409,11817,significantly increase,"On the nights with nicotine patch, as compared to the nights with placebo patch, TST (321.8 minutes vs. 422.7 minutes, p<0.01) and sleep efficiency (72.5% vs. 91.6%, p<0.01) were decreased and wakefulness after sleep onset (WASO) (97.8 minutes vs. 23.8 minutes, p<0.01), sleep latency to stage 2 (23.7 minutes vs 9.2 minutes, p<0.01), and sleep latency to REM stage (105.1 minutes vs. 74.9 minutes, p=0.05) were increased.",18042,18465,True
5438446,12301,significantly decreased,"The median number of visits to general practitioners for EDGE versus usual care were 4 versus 5.5 (P=.06) and to practice nurses were 1.5 versus 2.5 (P=.03), respectively",9905,10109,True
1783656,11615,significantly increase,"For the postprandial study the glucose incremental area under the curve (IAUC) following the IE meal was 40% greater than after either other meal (p < 0.001),",4722,4881,True
5984011,11703,no significant difference,No significant differences were observed among the three groups with respect to arousal score before treatment (p=0.07) and four (p=0.75) and eight (p=0.21) weeks after the intervention,27033,27218,True
5599826,13423,significantly decreased,eye open center of pressure-x (EO CoP-x) was significantly (p<0.05) decreased in AR group and yoga group.,11632,11737,True
4753023,13648,no significant difference,"the mean of birth weight in experimental group and control group were 3391/56 ± 422, 3314/06 ± 341, respectively and it was not significant difference (p = 0.2)",4729,4890,True
3499555,13435,significantly increase,mRNA testing has significantly higher specificity and PPV than DNA testing,91107,91182,True
3687098,13566,significantly increase,The incidence rate of the adverse event of constipation was higher in the sitagliptin group (2.3) than in the non-exposed group (1.8),37391,37525,True
3488177,12965,significantly decreased,Range of motion was 11° more in the non-tourniquet group (p = 0.001 at 2 years).,4753,4833,True
3681405,13682,no significant difference,"There were not significant differences between the two arms in the survival rates of stage I and stage IIIA NSCLC (log-rank P = 0.734; log-rank P = 0.051, respectively).",15356,15559,True
5066860,13456,significantly decreased,"a significant reduction in triglycerides, total and low-density lipoprotein cholesterol plasma levels",5559,5661,True
5866333,13741,significantly increase,"Sitagliptin enhanced stimulated GH secretion (P<0.01 versus placebo, for 30 minutes) and free insulin–like growth factor‐1 (P<0.001 versus placebo,",7610,7847,True
1925104,11272,significantly increase,". In the presence of a simultaneous distractor, the accuracy decreased (47%, F(1,11) = 23.90, p < 0.001) and the response time increased significantly (1369 ms, F(1,5) = 13.08, p < 0.05).",8821,9009,True
3751568,13848,significantly decreased,"Statistically significant pre-post improvements were made in thigh strength, child report of knee pain,",30303,30407,True
5769181,12544,significantly increase,"after intervention, the total mean score of self-care in all aspects of diabetes care for children was significantly higher in the experimental group (p < 0.001)",4553,4731,True
2699722,12607,no significant difference,"Interventions had no effect on LDL cholesterol values (P = 0.64),",4817,4902,True
3131514,12753,no significant difference,"Peripheral glucose uptake was not reduced by prednisolone 7.5 mg,",5103,5168,True
3680603,13744,no significant difference,"o groups. There were no statistical differences between fibrinogen, creatinine, lactate, and aspartate aminotransferase (AST) in the two groups",15138,15282,True
5878866,13877,no significant difference,t nine patients (22.5%) complained of nausea/vomiting in the TENS group compared to thirteen patients (32.5%) in the fentanyl group (P = 0.31).,6625,6785,True
3681405,13681,significantly decreased,"he median survival time (MST) in the preoperative chemotherapy arm was lower than that of surgery-alone arm (MST, 45.42 months vs 57.59 months) (P = 0.016).",4524,4698,True
1174954,13864,no significant difference,"The group given risedronate at 15 mg showed a trend towards improvement from baseline values, although the differences were not statistically significant (P values from 0.10 to 0.33).",22224,22424,True
3717757,13821,no significant difference,"HR genotype persistence was 30.4% (7/23) and 27.0% (17/63) in the control and vaccine arms, respectively (p=0.75).",44168,44282,True
5735450,13227,significantly decreased,"Incidence of coughing and POST at immediately, 1 h and 24 h postoperatively was significantly higher in air group compared to lignocaine group",4814,4957,True
3499555,13434,significantly increase,"mRNA had significantly more inadequate samples (36 vs. 14, p = 0.007).",36878,36949,True
3724383,13823,significantly increase,"After the treatment, stool frequency increased in both groups (P < 0.001), with greater increase in synbiotic + mineral oil group (P = 0.001).",4553,4733,True
1087853,11265,no significant difference,Statistical analysis revealed no significant differences in the mean HTLs of PTA and mean shifts of TEOAE's before and after genuine and/or sham mobile phone EMF 10 min exposure,4189,4366,True
3544627,13190,significantly decreased,participants rated less hunger and tended to rate lower desire-to-eat and greater satiety at 60min following the slow condition. T,39090,39220,True
3544627,13190,significantly decreased,"in the slow condition, hunger was significantly higher at 5, 10, 15, and 20min (p < 0.001) and was significantly lower at 60min (p = 0.003) compared with the fast condition",28936,29108,True
1968186,11274,significantly increase,"Response rates were 58% for CMF and 29% for epirubicin (chi 2 = 3.51, 1 d.f., P > 0.05).",1974,2062,True
5707237,12731,significantly decreased,showing the CG more connectivity between the left dorsal posterior cingulate cortex Brodmann Area (BA31) and the left piriform cortex (BA27) compared to the REHACOP group (t = 3.96; p = 0.04 FDR-corrected).,36119,36360,True
3695250,13595,no significant difference,"VAS scores for pain at rest or with movement at 1, 6, 24 and 48 h postoperatively were similar among the three groups",13431,13549,True
5873437,13589,significantly increase,Lille score calculation over that period showed 74.7% were responders (Lille < 0.45) in the ELAD group versus 47% in the control group (P < 0.01),82441,82606,True
2596788,12440,significantly increase,The GERD -education group scored at both times higher than the control group (p < 0.001).,19201,19291,True
5842245,13723,no significant difference,"Fisher’s exact test (two-tailed) gave a p value of 0.842 on comparing the number of participants who did at least one session of either intervention (iMBI or iMT),",33808,33989,True
5791469,11846,significantly increase,"pairwise comparison between groups indicated that there was statistically significant difference among face-to-face and control groups (P = 0.001), and group education and control group (P = 0.001) in terms of variable of informed choice",22762,23034,True
4390525,13881,,"In three groups of patients (G1–G3), a statistically significant (p < 0.05) saphenous nerve lesion was identified two weeks after the surgery.",-1,-1,False
3258705,13669,no significant difference,"he mean duration of infertility was 5.98 ±0.55 years in the control group and 7.81 ±1.37 years in the oestradiol group, but this difference was not statistically significant (P > 0.05).",14161,14364,True
4358417,13612,significantly decreased,"Abdominal total fat area, abdominal visceral fat area, body weight, and body mass index decreased significantly in the rosehip group at week 12 compared with their baseline levels (P<0.01) after receiving the rosehip tablet intake, and the decreases in these parameters were significantly higher when compared with those in the placebo group.",4946,5306,True
5830079,12027,no significant difference,There was no statistically significant effect on any other neonatal morbidity.,5555,5633,True
1968304,11430,no significant difference,"These findings suggest that, in clinical trials of adjuvant therapy for stage 2 breast cancer, the log rank test may be more sensitive to increases in tumour-related survival time than to increases in cured fraction.",2376,2593,True
3714386,12876,significantly increase,Patient and surgeon satisfaction scores were higher in group E and group NS (p<0.05) (,13997,14083,True
4360612,13445,significantly increase,"Six-month satisfaction rates were higher in the surgery group compared to the NSM group (79.0 vs. 27.3% very satisfied, p<.0001);",54700,54829,True
3659156,13464,significantly decreased,"Therapy based on impedance cardiography significantly increased the reduction in office systolic blood pressure (11.0 vs. 17.3 mmHg; p=0.008) and diastolic blood pressure (7.7 vs. 12.2 mmHg; p=0.0008); as well as 24-h mean systolic blood pressure (9.8 vs. 14.2 mmHg; p=0.026), daytime systolic blood pressure (10.5 vs. 14.8 mmHg; p=0.040), and night-time systolic blood pressure (7.7 vs. 12.2 mmHg; p=0.032).",5648,6141,True
3606616,11810,significantly increase,Mothers in the experimental group (n = 53) had a more positive breastfeeding experience according to the Breastfeeding Emotional Scale during the intervention than mothers in the control group (n = 50) (p-value = 0.022).,5898,6119,True
2699714,13773,significantly decreased,A1C at week 24 was lower in the etanercept group (5.91 ± 0.5%) compared with that in the placebo group (6.98 ± 1.2%; P < 0.05),5306,5450,True
4391304,12994,significantly increase,"After FM intake, fecal fat levels were significantly increased compared with those observed before FM intake in the active FM group, whereas no increase was observed in the control FM group",38244,38433,True
5845721,13516,no significant difference,No significant differences in changes in cardiovascular health indicators were observed between groups (p > 0.05),37161,37294,True
5739620,13872,significantly increase,"A significantly higher number of patients treated in the erythromycin arm developed moderate or severe skin toxicity according to WoMo score, i.e. ≥ 20 points (30/39 versus 23/41 patients, P = .049);",26296,26529,True
4265717,13573,significantly increase,"At both the 6- and the 12-month follow-ups, treatment outcomes (reduction in scores and positive provocative stress test) were significantly better in the urodynamic testing group than in the office evaluation only group (p-values significant for all outcomes).",5386,5647,True
1590049,11446,significantly decreased,"a mean rise of 50 × 106/L non CD3 lymphocytes during the first 24 weeks in the placebo arm compared with a mean decrease of 127 × 106/L from baseline in the active arm, a difference of 177 × 106/L (SE = 31, p < 0.001).",31411,31663,True
5883528,12952,significantly decreased,"The AUC(0–240) for the glucose response was significantly lower following HIT than MCT (10%, P = 0.008).",8364,8496,True
5654748,13471,significantly increase,"The Web 2.0 group had significantly higher average number of days per week with a step entry, average time per week on the website and average number of website visits per week at 0–3, 3–12 and 12–18 months compared with the Web 1.0 group",39607,39845,True
4796457,12590,significantly decreased,"before and after the treatment, a significantly statistical difference was observed in the number of urinary incontinence frequencies. (The experimental group: p = 0.001 and the control group: p = 0.002)",18315,18518,True
4796457,12590,significantly decreased,after the treatment was observed a significant statistical difference (p = 0.04),18614,18694,True
4218764,13827,significantly decreased,The cumulative sufentanil consumption in the PVB group (54.3 ± 12.1 μg) at 24 postoperative hours was more than 20% less than that of the control group (68.1 ± 9.9 μg) (P < 0.001).,5693,5890,True
4360612,13448,significantly increase,The difference in success rates was 56.6% (95% CI 41.4-70.0%) and the posterior probability that the success rate was higher in the SI joint fusion group was >0.999.,44236,44402,True
4232915,13045,no significant difference,"Both liarozole groups presented a higher number of AEs than the placebo group; however, the difference between groups was not significant (liarozole 75 or 150 mg vs. placebo, P ≥ 0·062),",33010,33230,True
3643134,12489,significantly increase,"students in the simulator group were significantly more likely to define the steps of cesarean section (91% vs 61.5%),",3868,3987,True
5440036,13438,significantly decreased,"Compared with Group P2.5, the CR rate was significantly improved at all intervals in Group P+D",4876,4970,True
4307366,12089,significantly decreased,a decrease in the subscales of self-isolation (p=0.004) and insecure/anxious (p=0.031) in risperidone group was significantly different from the buspirone group;,16705,16866,True
4987981,13296,no significant difference,"FPG (mg/dl)	2.2 ± 10.0	0.312	15.2 ± 19.2	0.002f 	20.5 ± 17.4	<0.001f 	0.021c, 0.002d,0.577e
Triglycerides (mg/dl)	1.1 ± 43.3	0.903	44.3 ± 45.4	<0.001f 	53.3 ± 36.9	<0.001f 	0.004c, 0.001d, 0.798e
HDL (mg/dl)	−1.7 ± 6.6	0.221	−1.9 ± 4.6	0.060	−1.5 ± 9.6	0.544	0.992c, 0.994d, 0.974e
SBP (mm Hg)	0.0 ± 8.6	1.000	1.7 ± 6.7	0.257	5.1 ± 6.3	0.005f 	0.725c, 0.094d, 0.354e
DBP (mm Hg)	0.3 ± 7.9	0.876	1.7 ± 4.2	0.077	4.1 ± 5.5	0.009f 	0.546c, 0.085d, 0.475e
Total Cholesterol (mg/dl)	1.4 ± 29.2	0.816	21.8 ± 25.2	0.001f 	24.0 ± 29.5	0.005f 	0.049c, 0.042d, 0.970e",28230,29502,True
5769202,13855,no significant difference,both Bates exercises and Trataka Yoga Kriya were not significantly effective in reducing refractive errors and in improving visual acuity (P value of refractive error in right eye: 0.4250; left eye: 0.4596; P value of visual acuity in right eye: 0.5691; left eye: 0.8952).,5034,5357,True
3611074,13469,no significant difference,The total number of patients displaying EA was 16 (41%) in the control group and 13 (32%) in the ketorolac group (P = 0.526),16249,16373,True
3622018,13478,no significant difference,This suggests that all interventions positively impacted QOL as measured by FACT-G.Table 7,66892,67011,True
3622018,13478,no significant difference,"PANAS-negative affect	Baseline	21.22 (9.96)	20.53 (6.78)	20.85 (7.39)
Post	17.47 (8.52)	16.78 (6.28)	17.35 (6.12)
Follow-up	19.23 (9.45)	15.57 (6.85)	16.88 (6.21)
PANAS -positive affect	Baseline	28.44 (7.76)	27.84 (6.70)	29.00 (8.02)
Post	29.24 (7.80)	31.11 (7.36)	30.75 (6.55)
Follow-up	31.77 (6.47)	34.14 (7.20)	33.76 (6.30)",70887,71866,True
4687062,13555,significantly increase,"At 4 days after PCI and injection, there was a clear correlation between anti-inflammatory and pro-inflammatory cytokines in the BMMNC group (Kendall’s tau 0.7, p<0.001) but not in the control group (Kendall`s tau 0.3, p = 0.17).",48331,48560,True
3668104,13751,,"no single answer, time sensitive",-1,-1,False
3493727,13080,no significant difference,There were three cases of mild hypoxemia in the propofol group and one in the combination group (p=0.362),17393,17498,True
4162033,13580,no significant difference,There was found no relationship between different doses of atorvastatin prescribed and ALT/AST changes in the patients.,4305,4424,True
3724383,13824,significantly decreased,"Straining at defecation, incomplete evacuation, and soiling decreased in both groups (P < 0.001), but more decrease was seen in the synbiotic + mineral oil group (P < 0.05).",4868,5081,True
4210953,13458,no significant difference,"Intervention and control groups did not differ significantly on their intake PHQ, GAD, or WSAS scores",28113,28215,True
5725027,13711,significantly increase,"The QoR-15 scores were significantly higher in the group D than in the group S on postoperative day (POD) 1, 2, 3 and 5 (P < 0.05).",5030,5162,True
3701780,12460,no significant difference,"After 6 months of statin therapy, NMD was not changed in both groups (from 19.4 ± 5.2% to 19.5 ± 4.9% in group I, from 20.5 ± 5.5% to 21.0 ± 5.4% in group II, p = ns).",17081,17265,True
4815896,13484,significantly decreased,"On day 7, reduction in MMP-8 levels (p = 0.0016) occurred in the MPT group,",9657,9750,True
4590707,13136,significantly decreased,"Restricting analyses to study subjects with a score above normal range, i.e. associated with a poor quality sleep/insomnia, this was reported more frequently by women in the placebo group compared with women in the melatonin group (49 vs. 23 %, respectively, p = 0.02)",29774,30060,True
2699714,13774,significantly increase,The percent change in C-peptide area under the curve from baseline to week 24 showed a 39% increase in the etanercept group and a 20% decrease in the placebo group (P < 0.05).,5600,5795,True
5096778,13870,no significant difference,No treatment differences were detected in the frequency intake of symptomatic medication (P=0.6),25056,25170,True
5041384,12764,significantly increase,Yoga group showed statistically significant (P < 0.001) reduction in aggression and significant (P < 0.001) enhancement in PA in comparison to the control group.,4524,4740,True
1526611,11604,,no single answer,-1,-1,False
1994017,11661,no significant difference,There was a trend (p=0.13) towards fewer severe bleeds in the fondaparinux group (1.0% vs 1.3% in the control group),2845,2961,True
4173586,12296,no significant difference,The grades of laryngoscopy [Table 3] between the two groups are also comparable (P = 0.104),14430,14577,True
5850179,13856,no significant difference,"There was no significant difference in major adverse cardiovascular events between patients who received morphine compared with those who did not (26.2% versus 22.0%, respectively; P=0.15).",20034,20241,True
3668104,13753,significantly decreased,"In the PACU, MAS was significantly high for 30 min in Group A compared to Group B and C (P < 0.05)",14081,14180,True
5741948,13729,no significant difference,"There were no differences in adjusted health and social care costs (£95, 95% CI -£1410 to £1599",13920,14016,True
1488896,11910,no significant difference,Secondary outcome measures included self-evaluations of well-being and feelings of loneliness.,5027,5121,True
1488896,11910,no significant difference,There was also no difference between study groups for any of the secondary outcome measures.,6059,6152,True
3525562,13393,significantly increase,"the self-esteem scores increased by 1.28 and decreased by 0.30 (p = 0.161) while the self-efficacy scores increased by 0.26 and decreased by 0.76 (p = 0.429) in the intervention and control group, respectively.",6604,6815,True
3751568,13850,no significant difference,no adverse events occurred.,6484,6511,True
5976899,13796,significantly increase,"the TPMM group had a better outcome (p < 0.05) in terms of ROM, kinesiophobia, depression, and QoL.",4335,4455,True
5516151,13663,significantly increase,"Mean estimated GFR (eGFR) plus or minus standard error at 7 years was 53.9 ± 1.9, 54.2 ± 1.9, and 35.3 ± 2.0 mL/min per 1.73 m2 for belatacept MI, belatacept LI and cyclosporine, respectively (p < 0.001",9913,10334,True
5704406,12737,no significant difference,"There was no significant change in hemoglobin or creatinine after CP therapy in either of the two groups (P = 0.587 and 0.936, respectively)",13868,14025,True
1550956,13668,no significant difference,"There was no significant difference between treatment groups in day 1 levels or the day 1 change in two other markers of coagulation, protein S (P = 0.41 and P = 0.59, respectively) and antithrombin III (P = 0.61 and P = 0.88, respectively)",21471,21780,True
5741948,13731,no significant difference,"there were no differences between the groups in the SF-36 mental component (−0.80, 95% CI -3.66 to 2.06), SF-36 physical component (−0.68, 95% CI -3.01 to 1.65)",14120,14281,True
4232915,13041,,no data on significance,-1,-1,False
1522015,13519,no significant difference,"The changes in normal (100%), low (4%), and very low (0.1%) illumination log CS were not statistically significant (p-values: 0.34, 0.23, and 0.32, respectively).",4319,4481,True
1174954,13866,significantly decreased,Risedronate treatment significantly reduced markers of cartilage degradation (Fig. 5) and bone resorption compared with placebo.,25746,25911,True
3474778,13783,significantly decreased,"The intervention was associated with reductions in the longitudinal prevalence of reported diarrhea of 53% among children <2 years (LPR = 0.47, 95% CI: 0.30–0.73, p = 0.001) a",7319,7517,True
5807510,13719,significantly increase,"the rate of genetic diagnosis within 28 days of enrollment (the primary end-point) to be higher in cases (31%, 10 of 32) than controls (3%, 1 of 33; difference, 28% [95% CI, 10–46%]; p = 0.003).",9987,10200,True
3590541,13047,no significant difference,The rise in peak airway pressure after carboperitoneum was comparable between the two groups,15272,15364,True
3258705,13672,no significant difference,"There were no significant differences in the mean number of retrieved oocytes, number of transferred embryos, or chemical and clinical pregnancy rates between the two groups.",6055,6230,True
2667135,12636,significantly decreased,"Persisting or relapsing S. aureus was less frequent in the CoPAT group (3.9% versus 15.5%, P = 0.007) and there were fewer deaths (3.9% versus 18.6%, P = 0.001) 6 weeks after the end of therapy",6329,6594,True
2667135,12634,significantly decreased,The shorter duration of study treatment for IPAT patients was influenced by early discontinuations: there were 53 (54.6%) versus 10 (9.7%) in the CoPAT group.,31368,31526,True
2836833,13762,,no comparison between ca groups,-1,-1,False
3931289,13626,no significant difference,"There was no change in Forced Expiratory Volume in one second, Gastroesophageal Symptom Assessment Score or CF Quality of Life score between the two treatment groups.",5453,5619,True
5827475,12477,significantly decreased,"expired tidal volume mean [SD] was significantly lower (5.5 [1.6] vs. 6.9 [2] ml/kg, P = 0.0017) with I-Gel™ compared to PLMA.",4754,4898,True
3264513,11960,significantly increase,"The isoenergetic dietary intervention significantly influenced whole-body insulin sensitivity (mixed-model analysis for repeated measures, treatment × time interaction, 0-18 weeks: p = 0.046;",47322,47514,True
3702089,12641,no significant difference,"Despite higher relative frequency of chemical pregnancy and ongoing pregnancy and lower rate of OHSS (moderate and severe) in the antagonist group, no significant difference was observed between 2 groups",13065,13269,True
3611074,13468,no significant difference,"There was no significant difference in the incidence of EA between control groups and the ketorolac group at 5 min (one patient, 3% vs. four patients, 10%, P = 0.360) and at 20 min (16 patients, 41 % vs 11 patients, 27%, P = 0.269).",16016,16248,True
5836873,12333,no significant difference,"No group differences were seen in PCS score,",10720,10816,True
3770494,13697,no significant difference,". In general, subjects who reported a treatment assumption of MPH or DNK recalled the last five words better than those who assumed placebo. There was, however, no difference between the real MPH and placebo groups.",25345,25560,True
3606612,13642,no significant difference,Overall adverse events were not different between the groups.,5123,5184,True
3695250,13594,significantly decreased,The total amount of fentanyl consumption was significantly lower in the K2 group (474 µg) compared to the control group (826 µg) and the K1 group (756 µg,5620,5773,True
5822856,13534,no significant difference,"A significant improvement was noted after 4 weeks in both G1 and G2 (p<0.0001), but not in CG (p=0.14 and p=0.64 for BBS and TUG, respectively) (Figure 3). No difference could be noted between G1 and G2.",20003,20308,True
3691658,12163,significantly increase,"PTH decreased in the high dose group, while it did not significantly change with low dose vitamin D",25007,25106,True
3691658,12163,significantly increase,"PTH (pg/ml)	36.7 ±17.1	31.6±11.5	--	--	0.17 d	30.4±13.5	25.0±10.0	--	--	0.04 d
35.5	29.4	31.1	21.7
(11.5-77.4)	(12.8-53.3)	(8.3-49.9)	(6.4-41.4",31984,33101,True
4757000,13583,significantly decreased,"Postoperatively, no pad usage was observed in 15 female patients in TOS group and in 11 female patients in the single-incision sling group at 6 months follow-up, therefore subjective cure rates were calculated as 75% and 55%, respectively (p=0.190) (Table-2).",17096,17394,True
2365983,13718,no significant difference,There were no differences in quality of life and total costs.,5164,5225,True
5866829,12782,significantly increase,"In the 10- and 15-mg groups, frequency of spontaneous bowel movements (±standard deviation) were significantly higher than baseline (5.7 ± 4.2 and 5.6 ± 3.5 times per week, respectively, compared with 2.6 ± 2.9 times per week in the placebo group [P = 0.0005, P = 0.0001, respectively])",4644,4964,True
2002515,11586,significantly increase,more participants in the valerian group perceived their sleep as better or much better (p = 0.04).,6569,6668,True
4687062,13553,no significant difference,"At 2 days, mean TnI concentration increased in both study groups (mean TnI control group, 3.0 SD 2.0; BMMNC group mean TnI, 3.3 SD 1.9) (Fig 1B). The difference between the groups was not statistically significant (p = 0.71).",35869,36146,True
1175919,11269,significantly decreased,"When comparing time to first shock between semiautomatic and automatic AEDs, the students were significantly faster in both evaluations using the semiautomatic device (first evaluation: 77.5 ± 20.5 s versus 85.2 ± 17 s, P ≤ 0.01;",14607,14854,True
1863514,11307,,no single answer,-1,-1,False
1586021,11364,no significant difference,"there were about twice as many recanalizations as failures in both groups in the FI trial. The risk of early recanalization was similar whether or not the men experienced a vasectomy related adverse event (without FI 32% vs 24%, p = 0.15; with FI 10% vs 11%, p = 0.83).",26520,26789,True
4360612,13446,no significant difference,"The mean number of adverse events in the first six months was slightly higher in the surgical group compared to the non-surgical group (1.3 vs. 1.0 events per subject, p=0.1857).",5860,6038,True
4265717,13572,significantly decreased,the urodynamic testing group had a 3.3% rate of positive provocative stress test compared with 13.3% in the office evaluation only group (p<0.001).,20404,20551,True
4161875,13700,significantly decreased,"Mean daily costs per patient were significantly reduced with EUR 12 (95% CI −32 to −18, P = 0.02) in the intervention group.",6296,6441,True
1821028,11434,no significant difference,"Anethum could reduce total cholesterol by 0.4 % and LDL-cholesterol by 6.3% but these were not significant statistically (P-value: .828, and .210, respectively).",4146,4308,True
1488900,11476,significantly decreased,"Overall asthma symptoms improved in the azithromycin group (+0.55) and worsened in the placebo group (−0.13). The effect size (+0.68; 0.05, 1.29) in favor of azithromycin was statistically significant (p = 0.04)",26781,27009,True
37407,11551,no significant difference,"The mean gastric residual volume after feeding for 3 hours in the prone position was 59.7 ml (range, 0-200 ml), compared with 59.5 ml (range, 0-180 ml) after 3 hours in the supine position (P = 0.69).",10028,10245,True
5844532,13770,significantly decreased,"During the first month of treatment, a significant decrease in the cross-sectional area (CSA) was found in the Equitend® group (p = 0.04). After 4 months, the number of Equitend® treated horses with an improved CSA was significantly higher than the placebo-treated horses (p = 0.03571).",18965,19274,True
3511174,13609,significantly increase,"At Baseline, the only significant group difference was higher forearm supination resistance torque in group B than in group BT (p = .05).",25951,26105,True
3685700,13684,no significant difference,the change in hunger induced by the preload was similar between the sleep and TSD conditions.,4862,4956,True
4550271,13315,no significant difference,"the proportion of patients who tested positive and received (or were prescribed) an ACT was lower in the intervention arms, but these differences were not statistically significant",63784,63964,True
1190216,11236,significantly increase,"Intramuscular administration of seminal plasma resulted in a higher ovulation rate than intrauterine administration of seminal plasma (93% versus 41%; P < 0.01),",4577,4738,True
3695250,13596,no significant difference,patient satisfaction were not significantly different among the groups.,5880,5951,True
3590691,12317,,no data,-1,-1,False
5745479,13644,significantly increase,"A significantly higher proportion of any AEs (diarrhoea or nausea or rash) (OR = 1.31, 95% CI 1.05–1.64, number needed to harm (NNH) = 24) and of diarrhoea (OR 1.43 95% CI 1.08–1.90, NNH = 29) was reported in the amoxicillin group during the first week after randomisation.",7112,7386,True
3622018,13476,significantly increase,"MBB group showed reductions in self-reported depression symptoms (p = .040) and improvements in overall levels of mindfulness (p = .018), self-compassion (p = .028), and well-being (p = .019) at postintervention.",4779,5059,True
3280326,12352,significantly increase,"Participants seen at least once with a helmet amounted to 6.6% of all observed participants (Table 2), with higher rates in the two groups who received a helmet at baseline (helmet only: 11.4%; helmet and information: 9.2%) as compared with the others (control: 3.7%; information only: 3.2%; p = 0.008).",32680,33037,True
3680656,12354,significantly decreased,"memantine-treated patients significantly outperformed placebo-treated patients on the SIB (least squares mean difference [95 % CI] 2.6 [1.0, 4.2]; p = 0.001),",6278,6471,True
3695250,13597,no significant difference,the incidence of adverse events and patient satisfaction were not significantly different among the groups.,5844,5951,True
4644318,13799,no significant difference,"Effective pain relief [numeric rating scale (NRS) < 3] was observed in 77.3% (95% CI: 67‒90.5%) of patients in PIL group and 74.2% (95% CI: 62.4 - 89.4%) of patients in the TF group (P = 0.34),",5300,5494,True
2784391,12042,significantly increase,"CSD of the right vastus intermedius decreased significantly less in the EMS group (-0.10 ± 0.05 cm, -12.5 ± 7.4%) as compared to the control group (-0.29 ± 0.28 cm, -21.5 ± 15.3%; P < 0.05).",6443,6654,True
4354798,12863,no significant difference,"For CGI improvement scores, neither patients’ self-ratings (P=0.384) nor clinicians’ ratings (P=0.448) showed a significant difference between treatment groups.",21079,21274,True
2526991,13095,significantly increase,The duration of therapeutic effect of Garcinia kola was longer than the placebo (p > 0.001).,6250,6367,True
3511174,13607,no significant difference,"Both groups had very small improvements in AHA and Melbourne two months after BoNT-A injections, without differences between groups.",5096,5228,True
3643086,13737,no significant difference,"No significant difference was observed on the temporal variation of biomarker levels (IL-6, VCAM-1, ET-1) between treatment and control groups.",5910,6054,True
5244530,13818,no significant difference,"There were no significant differences between the intervention and control group in depression severity reduction or remission rate, change in quality of life, psychological well-being, sedative prescriptions, or sick leave",8377,8600,True
3562202,11733,significantly increase,"Increased maximal isometric joint torque, agonist EMG and peak power were significantly greater following HYBRID vs. FTP (p < .05)",6250,6397,True
4763470,12380,significantly decreased,"TG declined, and HDL-C enhanced significantly in C. ficifolia plus yogurt group (P < 0.001and P = 0.001, respectively",15817,15992,True
3622018,13475,significantly decreased,"mean sleep disturbance symptoms in the MBB (p = .0029) and MM (p = .0499) groups were lower than in the SHE group,",4523,4672,True
5777419,13506,no significant difference,"In the probiotic group, we observed attachment gain, reduction of PPD, and reduction of plaque, which was not significant when compared with the other groups",48168,48326,True
3611074,13470,significantly decreased,"There was a significant difference in the number of children who received fentanyl for analgesia after 20 min in the PACU when comparing the control group (13/39, 33%) to the ketorolac group (5/41, 12%) (P = 0.046).",16833,17048,True
5319516,13656,no significant difference,", triglycerides, total cholesterol (TC), LDL-cholesterol (LDL-C), and apolipoprotein B100 (ApoB100) levels were decreased in the ZA10 group (−64%, −37%, −46%, and −54%, respectively, compared with baseline), and these changes were similar to those of the A40 group (P > 0.05).",5571,5886,True
5777424,13841,no significant difference,"The preemptive administration of etodolac in a single dose 1 hour prior to in-office tooth bleaching did not alter tooth color, and the risk and intensity of tooth sensitivity reported by patients.",4940,5137,True
3695249,13538,significantly decreased,"Patients who were given the rescue antiemetic were censored and Kaplan-Meier analysis of the interval to first rescue antiemetic showed a significant intergroup difference (Fig. 1) between the palonosetron and ondansetron (P < 0.001), palonosetron and ramosetron (P < 0.001), and ondansetron and ramosetron (P = 0.042) groups.",16025,16389,True
3531427,11741,no significant difference,High dose iloprost inhalation was similar to placebo in regard to walking distance (p = 0.98),30484,30577,True
3770450,13465,significantly increase,Serum P1NP increased significantly after Thai traditional massage (P <0.01),3866,3958,True
3636834,13131,,no data,-1,-1,False
1783656,11614,significantly decreased,Fasting 4 wk insulin was 10% lower after PHSO (p > 0.05) and 22% lower after IE (p < 0.001) compared to POL,4614,4721,True
5984413,13395,no significant difference,There was no statistically significant difference between Treatment and Placebo for hits,5965,6053,True
5850768,13735,no significant difference,The overall efficacy did not differ from what had been observed at week 30 (ACR20 responses in PPS: 64.1% in SB2 and 66.0% in INF; ACR20 responses in FAS: 63.6% in SB2 and 65.3% in INF).,25037,25224,True
5799990,13162,no significant difference,"there was no statistically significant difference in periapical healing between teeth in subgroups IA, IB, IIA, and IIB at the baseline, 1-, 3-, or 6-month evaluation with P = 0.342, 0.839, 0.218, and 0.780, respectively.",14496,14734,True
1065070,13795,significantly increase,"EVLWIG in the OA group increased by 4.7 ml/kg and 5.6 ml/kg relative to the LPS and the sham-operated groups, amounting to increments by 65% and 90%, respectively (P = 0.001).",18147,18351,True
3724383,13826,no significant difference,No severe side-effects were observed in any group.,5197,5248,True
3474842,12538,no significant difference,We observed a non-significant reduction in staff: 46/216 (21%) in T facilities versus 47/350 (13%) in T&P facilities (p = 0.5).,10071,10198,True
5319516,13657,no significant difference,"CT-1 and high sensitivity-C reactive protein (hs-CRP) levels were significantly decreased in the ZA10 group after 4 and 8 weeks (4 weeks: −73% and 96%; 8 weeks: −89% and −98%; all P < 0.01), without differences among the 3 groups (P > 0.05).",5887,6185,True
5866333,13740,significantly increase,"Vasodilation and tPA increased in all patients, but sitagliptin enhanced vasodilation (P=0.01 versus placebo) and increased tPA (P<0.001) in women only.",7888,8181,True
1065065,13786,no significant difference,"No significant differences were found between the intravenous lornoxicam and placebo groups in major cytokines, duration of ventilation and length of intensive care unit stay, and inspired fractional oxygen/arterial oxygen tension ratio (P > 0.05).",4569,4834,True
5614421,12427,no significant difference,"No differences were seen between study groups for other respiratory morbidities and adverse infant outcomes, including serious infant composite outcome",16347,16499,True
5739620,13871,no significant difference,"the time to the onset of skin toxicity of NCI CTCAE grade ≥ 2. In the doxycycline arm median time was 43 days (day one of cycle 4), in the erythromycin arm median time was 29 days (day one of cycle 3) without statistical significance in the corresponding logrank test (P =.68).",23237,23548,True
4951149,13677,significantly increase,Bowel movements over the three-day registration period rose from a median of 4 (total range 1–8) during the WSD to 5 (total range 2–13) (P < 0.01) during the HCD. The faecal consistency differed significantly (P = 0.02) between the two interventions,52204,52501,True
2836833,13763,no significant difference,Diet had no significant effect on either systolic or diastolic blood pressure,26288,26365,True
3714385,13651,no significant difference,"HOMA-β values at 60 min after the start of surgery and skin closure were significantly lower in Group L than in the Group H, but significant difference was not noted.",19096,19262,True
59610,11164,no significant difference,Randomized studies have shown that LMWHs are as effective as unfractionated heparin in the prevention of recurrent venous thromboembolism,2615,2752,True
1797029,11311,,no data,-1,-1,False
4105274,13889,no significant difference,"the knee flexion range of motion of the patients in the active treatment group was 5.5 less, on average, than that of patients in the control group. The lower and upper 95% CIs were −11 and 0.25, P-value was 0.068, and the difference between the two treatment arms was not statistically significant.",25756,26072,True
5725027,13713,significantly decreased,The incidence of nausea was significantly lower in the Group D.,5424,5487,True
2365983,13715,significantly increase,Median operating time was longer in the total laparoscopic compared with the hand-assisted laparoscopic group (298 vs. 214 minutes; P < 0.001).,4530,4707,True
4768925,13474,significantly decreased,. The NIHSS score and levels of ACTH and COR of the treatment group were significantly lower than those of the control group (p<0.05).,4590,4725,True
4644318,13802,no significant difference,There were no adverse effects observed in any of our patients.,5816,5878,True
3578670,12820,significantly decreased,"The ocular discomfort (expressed as mean [standard deviation]) with brinzolamide/timolol was significantly lower than with dorzolamide/timolol (day 2:1.9 [2.3] versus 3.7 [2.8], respectively [P = 0.0003];",4755,4980,True
5769191,13619,no significant difference,"Although insignificant, the rate of pregnancy in the intervention group was higher than the control group.",4924,5031,True
4722945,11712,significantly increase,Transient head or facial discomfort was reported after 19 (25%) intranasal glucagon administrations and after 7 (9%) intramuscular administrations.,35801,35948,True
65514,12288,no significant difference,there was also no statisticaly significant difference in the changes of all tested blood parameters between the two products,5096,5220,True
4990415,13861,significantly decreased,"GSLiM participants also achieved significant improvement in total weight self-efficacy score, negative emotions and physical discomfort subscales,",10440,10587,True
3881817,13508,,no comparison,-1,-1,False
5819581,13420,,"A significant change in total cell count and neutrophil, lymphocyte, and macrophage counts in sputum samples were observed in the patients receiving either of the two treatments (IPV and HFCWO) compared to control group. no data",-1,-1,False
2797957,13878,no significant difference,There was no significant difference in mean change TPS between Sativex and placebo (P = 0.40; SEM 9.5; 95% CI −11.3 to 27.8) at end point,8406,8560,True
3751503,13654,no significant difference,Active flexion ROM significantly improved from pre-op to 24-month follow-up (P < 0.0001) with no difference between groups at any time point.,5346,5508,True
2365957,13451,no significant difference,no differences between the FPV/r100 and ATV/r100 arms in proportion of patients achieving HIV-1 RNA < 50 copies/mL in the ITT,22346,22471,True
5866333,13739,significantly increase,"Sitagliptin enhanced stimulated GH secretion (P<0.01 versus placebo, for 30 minutes)",7610,7763,True
5155184,12542,significantly increase,patient and physician satisfaction were both significantly higher in the nitrous oxide compared with the control group (P < 0.05).,5194,5344,True
3636944,12622,no significant difference,The intergroup comparison of PI scores and PPD showed no significant difference (data not shown).,11948,12046,True
3680603,13743,no significant difference,"Cardiac markers (isoenzyme creatine kinase with muscle and brain subunits [CK-MB] or troponin-I) and the brain natriuretic peptide level were significantly higher in both groups than the respective preoperative values (p<0.05), but there were no significant differences between the two groups.",14854,15148,True
1277845,11460,no significant difference,"Insulin concentration for the inactivity and the activity (30, 60, or 90 min treadmill walking) trials. For better readability the symbols of the different trials at the same time points are slightly staggered. Values are means (standard error of the mean). Overall mixed analysis with repeated measurements, effect of trial: P = 0.16.",17331,17666,True
1702540,11348,significantly decreased,the trained hungry subjects estimated their glycemia (78.1 ± 6.7 mg/dL; estimation error: 3.2 ± 2.4% of the measured glycemia) more accurately than the control hungry subjects (75.9 ± 9.8 mg/dL; estimation error: 16.7 ± 11.0%; p = 0.0001),4132,4371,True
4407951,12765,no significant difference,"The differences between the groups were not significant (P = 0.52 at 4 months, P = 0.79 at 1 year). The corresponding utility weights and QALY changes are presented in Figure 1. The QALYs gained correspond to an extra 3.7 days in the best imaginable health status for the Internet group and to 3.3 days for the postal group.",32999,33400,True
5739614,13020,significantly decreased,the trimetazidine group had also significantly lower serum hs-CRP,5153,5219,True
5739614,13020,significantly decreased,the trimetazidine group had also significantly lower serum hs-CRP,5153,5219,True
1971800,11977,,no data on size,-1,-1,False
4681154,13210,significantly increase,"NRS score changes were greater in group L than in group S (P < 0.01, ANOVA",6827,6918,True
3354371,12062,significantly decreased,incidence of apnoea was more in group II (P<0.05).,10544,10614,True
4733100,13791,no significant difference,intervention participants had significantly increased odds of meeting the U.S. recommended guideline of ≥ 150 min/week of at least moderate-intensity physical activity at 12 months for the modified CHAMPS (odds ratio [OR] = 2.86; 95% CI: 1.03–7.96; p = 0.04) but not at 6 months (OR = 1.54; 95% CI: 0.56–4.23; p = 0.40).,5506,5827,True
4588995,13374,no significant difference,"n comparing the two groups, there were no differences in magnitudes of score improvement for PRO measures, VAS, or satisfaction.",6599,6727,True
5388709,13427,no significant difference,"he percentage change in fresh muscle HRT was not significantly different between the BA (0 ± 9 ms; +1 ± 15%) and PLA group (+7 ± 10 ms; +12±15%) with a medium effect reported (P = 0.10, Cohen’s d = 0.7).",50163,50400,True
32174,11177,no significant difference,"Significantly more PHR than control group patients felt that they had made a complete recovery from the stroke (38% vs. 14%, p=0.01), and a higher proportion felt that they had ""got their lives back together again"" (48% VS. 31%, P=0.08).",24385,24622,True
3354371,12064,,no single answer,-1,-1,False
3641305,13759,,no fig 5,-1,-1,False
1208905,13621,no significant difference,"Dyspnea scores were slightly higher for patients receiving true versus placebo acupuncture, for both the period immediately following acupuncture treatment and for the daily one week follow-up (differences between means of 0.34, 95% C.I. -0.33, 1.02 and 0.56, 95% C.I. -0.39, 1.51).",4648,4931,True
3640933,12528,no significant difference,There were no significant effects on the odds of intention to smoke or smoking behaviors.,5282,5371,True
2528216,13394,no significant difference,"Mean (SE) minutes of activity during 2 weeks prior to each visit as reported through the activity questionnaire. Although not significantly different by statistical analysis, patients receiving tiotropium reported approximately 216 minutes more physical activity as compared with patients receiving placebo at week 25.",24909,25227,True
1224861,11629,significantly increase,"Those patients undergoing off-pump surgery had significantly poorer left ventricular function than those undergoing on-pump surgery (28.6 ± 5.8% vs. 40.5 ± 7.4%, respectively, p < 0.05) and also had higher Euroscore values (7.26 ± 1.4 vs. 12.1 ± 1.8, respectively, p < 0.05).",3643,3956,True
4990415,13859,,no data for BMI,-1,-1,False
3510891,12780,no significant difference,"Measurements of reaction time, kinetic time, α-angle, maximum amplitude and coagulation index before and after colloid infusion did not differ between the groups.",3954,4116,True
3483098,12045,significantly decreased,"The mean difference in HbA1c was –0.43% (–4.74 mmol/mol) in favour of the Sensor On arm (8.04% [64.34 mmol/mol] vs 8.47% [69.08 mmol/mol]; 95% CI −0.32%, −0.55% [−3.50, −6.01 mmol/mol]; p < 0.001).",5221,5446,True
4751201,11679,significantly increase,PTG system resulted in lower canal transportation than PTU system at the curved part. Canal transportation was higher at the curved canal portion (p < 0.0001).,5569,5749,True
